Formulary

Report : A-Z of formulary items 26/03/2019 04:57:33

Section	Name	Details
16.01	Resource Thicken Up Clear^®
06.01.01.02	Insulin glargine 300units/ml Toujeo	Solution for injection (injection). Solostar PRESCRIBE BY BRAND High strength insulin glargine - 300 units/ml
20	5-Fluorouracil	7.5mg in 0.3ml injection Approved by HaRD Area Prescribing Committee June 2014
05.03.01	Abacavir Ziagen^®	Commissioned by NHS England. All patients should routinely be started on Homecare
05.03.01	Abacavir and Lamivudine and Zidovudine Trizivir^®	Commissioned by NHS England All patients should be routinely initiated on Homecare - not stocked at HDH
10.01.03	Abatacept Orencia^®	Initiation by Consultant Rheumatologists only. Commissioned by NHS England
24.16	Abidec Neonatal	For all pre-term infants < 34 weeks gestation and/or <1500g birth weight. Dose: 0.6ml once daily (unlicensed dose) Commence when tolerated milk feed (formula or breast) ≥ 165ml/kg/day. Continue up to 6-12 months of age depending on diet. Dalivit® is available when there are supply problems with Abidec, however the dose is 0.3ml daily due to the higher vitamin A content.
08.03.04.02	Abiraterone Zytiga^®
04.10	Acamprosate Calcium Campral EC^®	Tablets 333mg Initiation on the advice of a Psychiatrist
11.06	Acetazolamide Diamox^®	Tablets 250mg MR capsules 250mg
12.01.01	Acetic acid solution	Solution 3%, 5%
03.07	Acetylcysteine effervescent tablets 600mg NACSYS	Prescribe by brand (NACSYS brand) NACSYS 600 mg effervescent tablets is indicated in adults only.
18	Acetylcysteine infusion Parvolex^®
24.01	Acetylcysteine injection
05.03.02.01	Aciclovir	Tablets 200mg, 400mg, 800mg Infusion 250mg/10ml, 500mg/20ml (hospital only)
11.03.03	Aciclovir Zovirax^®	Eye ointment 3% - Discontinued December 2018 - switch to ganciclovir
24.01	Aciclovir	Oral - follow BNFc IV - follow dosing and administration guide
24.16	Aciclovir Neonatal
13.10.03	Aciclovir 5% cream
13.05.02	Acitretin Neotigason^®
03.01.02	Aclidinium bromide Eklira Genuair^®	Licensed for COPD only
01.05.03	Adalimumab Humira^®	Consultant request only Commissioned by NHS England for paediatric uveitis, juvenile arthritis and paediatric indications (where adult TA available)
10.01.03	Adalimumab Humira^®	Initiation by Consultant Rheumatologists only
13.05.03	Adalimumab Humira^®	Initiation by consultant Dermatologist only
13.06.01	Adapalene Differin^®
13.06.01	Adapalene & Benzoyl Peroxide Epiduo^®	Approved by HaRD Area Prescribing Committee September 2013
02.03.02	Adenosine Adenocor^®	Injection 6mg/2ml
24.01	Adenosine
24.01	Adrenaline
24.16	Adrenaline Neonatal
02.07.03	Adrenaline / Epinephrine Adrenaline / Epinephrine 1 in 10000, dilute
03.04.03	Adrenaline / Epinephrine Adrenaline / Epinephrine 1 in 1000	Injection 1:1000 1mg/ml
03.04.03	Adrenaline / Epinephrine Adrenaline / Epinephrine 1 in 10000, dilute	Injection 1mg/10ml Pre-filled syringe 1mg/10ml
03.04.03	Adrenaline / Epinephrine Minijet^® Adrenaline 1 in 10000	Minijet 1mg/10ml
03.04.03	Adrenaline / Epinephrine Emerade^®	500 micrograms solution for injection in pre-filled pen
03.04.03	Adrenaline solution 500mcg/0.5ml PFP (Emerade) ^®	Emerade pre-filled pen delivers a single dose of 0.5ml containing 500 micrograms of adrenaline (as tartrate).
14.04	Adsorbed Diphtheria [low dose], Tetanus and Inactivated Poliomyelitis Vaccine Revaxis^®
14.04	Adsorbed Diphtheria [low dose], Tetanus, Pertussis (Acellular, Component) and Inactivated Poliomyelitis Vaccine Repevax^®
08.01.05	Aflibercept Zaltrap^®	NICE TA307: Aflibercept in combination with irinotecan and fluorouracil-based therapy for treating metastatic colorectal cancer that has progressed following prior oxaliplatin-based chemotherapy
11.08.02	Aflibercept Eylea^®
13.11.01	Alcohol Industrial Methylated Spirit BP
08.02.03	Alemtuzumab MabCampath^®	Commissioned by NHS England for the treatment of multiple sclerosis, pre-transplant immunosupression and chronic lymphocytic luekemia (CLL)
06.06.02	Alendronic Acid	Tablets 70mg
09.06.04	Alfacalcidol	Capsules 0.25micrograms, 1microgram
24.01	Alfamino	Paediatric Nutritional Products List - approved APC 05/18
15.01.04.03	Alfentanil Rapifen^®
17	Alfentanil	Opiate of choice in severe renal impairment
20.01	Alirocumab Praluent^®	First line in patients with LDL 3.5-4 (target LDL level 1.8) and in primary prevention (FH) with LDL > 5
02.05.05.03	Aliskiren Rasilez^®	Tablets 150mg For use by Renal Unit patients or on the advice of a specialist only
13.05.01	Alitretinoin Toctino^®	Consultant Dermatologist recommendation only
10.01.04	Allopurinol	Tablets 100mg, 300mg
02.14	Alprostadil Prostin VR^®	Injection 500microgram/ml For use in neonates only
07.04.05	Alprostadil Caverject^®
07.04.05	Alprostadil MUSE^®
07.04.05	Alprostadil Vitaros^®	Approved by the HaRD Area Prescribing Committee, February 2015. To be prescribed on the recommendation of a Consultant Urologist ONLY.
24.16	Alprostadil Neonatal	500microgram/ml injection
02.10.02	Alteplase Actilyse^®	Injection 20mg, 50mg For specialist use only
24.01	Althera
13.12	Aluminimum Salts Anhydrol Forte^®
09.05.02.02	Aluminium Hydroxide Alu-Cap^®	Capsules 475mg Initiation on the advice of a Renal Specialist
01.02	Alverine Citrate Spasmonal^®
04.09.01	Amantadine Hydrochloride Symmetrel^®
05.01.04	Amikacin
02.02.03	Amiloride Hydrochloride
03.01.03	Aminophylline	Injection 250mg/10ml Phyllocontin MR tablets 100mg, 225mg Prescribe by brand for different MR formulations of theophylline and aminophylline to avoid confusion between them.
24.01	Aminophylline
24.01	Amiodarone
02.03.02	Amiodarone Hydrochloride	Tablets 100mg 200mg; Injection 150mg/3ml; Minijet 300mg/10ml
04.02.01	Amisulpride	Tablets 50mg, 200mg Liquid 500mg/5ml
04.07.03	Amitriptlyine	Tablets 10mg, 25mg, 50mg Liquid 50mg/5ml
04.03.01	Amitriptyline Hydrochloride	Tablets 10mg, 25mg, 50mg Liquid 50mg/5ml
02.06.02	Amlodipine	Tablets 5mg, 10mg
05.01.01.03	Amoxicillin	Capsules 250mg & 500mg Syrup 125mg/5ml & 250mg/5ml Injection 250mg, 500mg and 1g powder (hospital only)
24.01	Amoxicillin	Oral - follow BNFc IV - follow dosing and administration guide
24.16	Amoxicillin Neonatal
11.99.99.99	Amphotericin
09.01.04	Anagrelide Xagrid^®	Capsules 500micrograms Initiation by Consultant Haematologists only
08.03.04.01	Anastrozole Arimidex^®	Tablets 1mg
15.02	Antacid with Oxetacaine
14.05.03	Anti-D (Rh₀) Immunoglobulin Rhophylac^®
02.08.02	Apixaban Eliquis^®	See NICE guidance.
04.09.01	Apomorphine Hydrochloride APO-go^®	Injection 20mg/2ml, 50mg/5ml Initiation on the advice of a specialist
13.02.01	Aqueous Cream BP ZeroAQS^®	100g, 500g
13.09	Arachis (peanut) oil Extract of Coal Tar 0.3%, Cade Oil 0.3%, Coal Tar Solution 0.1%, Oleyl Alcohol 1% and Tar 0.3% Polytar^®
02.08.01	Argatroban Exembol^®
04.02.01	Aripiprazole Abilify^®	Tablets 5mg, 10mg, 15mg - Not Stocked Initiation by Consultant Psychiatrists only, requested through LPG on an individual patient basis.
05.04.01	Artemether with lumefantrine Riamet^®	On the advice of the Infectious Diseases Team at Leeds
12.03.05	AS saliva Orthana^®	Product is of animal origin (procine) so therefore not suitable for all patient groups.
09.06.03	Ascorbic Acid	Tablets 50mg, 200mg, 500mg
04.07.01	Aspirin	Soluble tablets 300mg
02.09	Aspirin (antiplatelet) Aspirin^®	Dispersible tablets 75mg Not to be used as monotherapy for atrial fibrilation
02.04	Atenolol	Tablets 25mg, 50mg, 100mg; Liquid 25mg/5ml; Injection 5mg/10ml
04.04	Atomoxetine Strattera^®	Capsules 10mg Initiation on the advice of a specialist
02.12	Atorvastatin Lipitor^®	Tablets 10mg, 20mg, 40mg, 80mg Initiation by a specialist only. Atorvastatin 80mg OD for use post ACS for 6 months then switch to simvastatin 40mg if target cholesterol achieved.
07.01.03	Atosiban Tractocile^®	Injection 7.5mg/ml (5ml) Concentrate for infusion 7.5mg/ml (0.9ml)
24.16	Atracurium Neonatal
15.01.05	Atracurium Besilate
24.16	Atropine Neonatal
11.05	Atropine Sulphate	Eye drops 1% Eye ointment 1%
15.01.03	Atropine Sulphate
07.04.05	Avanafil Spedra^®
08.01.03	Azacitidine Vidaza^®
08.02.01	Azathioprine	Tablets 25mg, 50mg
10.01.03	Azathioprine	Tablets 25mg, 50mg
13.05.03	Azathioprine	Tablets 25mg, 50mg This is to be used with the shared care guidelines - see link. * Note this is for an UNLICENSED indication*
13.06.01	Azelaic Acid Finacae^®
12.02.01	Azelastine Hydrochloride Rhinolast^®	Aqueous nasal spray 140micrograms/metered spray
05.01.05	Azithromycin	Long term use of Azithromycin in non – cystic bronchiectasis is an ‘off-label’ use for azithromycin. To be initiated by the specialist Respiratory Team only.
05.01.02.03	Aztreonam Azactam^®	Injection 1g powder
10.02.02	Baclofen	Tablets 10mg Liquid 5mg/5ml
01.05.01	Balsalazide Sodium Colazide^®	Capsules 750mg
10.01.03	Baricitinib Olumiant
13.02.02	Barrier preparation Conotrane^®	100g
13.02.02	Barrier preparation Sudocrem^®
13.02.02	Barrier preparation Metanium^®	Ointment 30g
13.02.02	Barrier preparation Siopel^®	50g
24.16	BCG vaccination Neonatal
14.04	BCG vaccine diagnostic agent Tuberculline Purified Protein Derivative (PPD)
14.04	BCG vaccine Intradermal Bacillus Calmette-Guerin Vaccine
03.02	Beclometasone Dipropionate Beclazone Easi-Breathe^®	100 micrograms/dose, 250 micrograms/dose
03.02	Beclometasone Dipropionate Clenil Modulite^®	50 micrograms/dose, 100 micrograms/dose, 200 micrograms/dose, 250 micrograms/dose Prescribe by brand. Clenil Modulite is not interchangeable with other CFC-free inhalers.
03.02	Beclometasone Dipropionate Qvar^®	100 micrograms/dose Easi-breathe inhaler Prescribe by brand. Qvar is not interchangeable with other CFC-free inhalers.
12.02.01	Beclometasone Dipropionate Beconase / Nasobec	Aqueous nasal spray 50micrograms/spray
24.01	Beclometasone inhaler
03.01	Beclometasone, Formoterol and Glycopyrronium Trimbow^®	Each metered dose (the dose leaving the valve) contains 100 micrograms of beclometasone dipropionate, 6 micrograms of formoterol fumarate dihydrate and 10 micrograms of glycopyrronium (as 12.5 micrograms glycopyrronium bromide).
03.02	Beclometasone/formoterol Fostair^®	Aerosol inhaler (licensed for both asthma and COPD) NEXThaler® (licensed for asthma only) Beclomethasone 100 micrograms/ formoterol 6 micrograms Equivalent to Seretide 125 and Symbicort 200/6. For initiation by respiratory specialists only.
20	BENZBROMARONE Tablets 100 mg, 50mg	For patients intolerant to allopurinol and febuxostat only.
03.08	Benzoin Tincture Compound BP Friar's Balsam
13.06.01	Benzoyl Peroxide PanOxyl^®	Gel 2.5%, 10%
13.06.01	Benzoyl Peroxide 5% with Clindamycin 1% Duac^® Once Daily
12.03.01	Benzydamine Difflam	Oral rinse Spray
24.01	Benzydamine oral spray
05.01.01.01	Benzylpenicillin	Injection 600mg & 1.2g powder
24.01	Benzylpenicillin
24.16	Benzylpenicillin Neonatal
04.06	Betahistine Dihydrochloride	Tablets 8mg
11.04.01	Betamethasone	Eye drops 0.1% Eye ointment 0.1%
13.04	Betamethasone (as Dipropionate) 0.05% with Salicylic Acid 3% Diprosalic^®
13.04	Betamethasone (as Valerate) 0.025% Betnovate-RD^®
13.04	Betamethasone (as Valerate) 0.1% Betnovate^®
13.04	Betamethasone (as Valerate) 0.1% with Clioquinol Betnovate-C^®
13.04	Betamethasone (as Valerate) 0.1% with Fucidic Acid 2% Fucibet^®
11.04.01	Betamethasone 0.1% with Neomycin 0.5%	Eye drops Eye ointment Temporarily discontinued
12.01.01	Betamethasone Sodium Phosphate	Ear/Ear/Nose drops 0.1%
12.02.01	Betamethasone Sodium Phosphate 0.1%	Eye/Ear/Nose drops
12.01.01	Betamethasone Sodium Phosphate 0.1% with Neomycin Sulphate 0.5%	Eye/Ear/Nose drops (betamethasone 0.1%/ neomycin 0.5%)
11.06	Betaxolol Hydrochloride Betoptic^®	Eye drops 0.5%
08.01.05	Bevacizumab Avastin^®
11.08.02	Bevacizumab Avastin^®	Intravitreal injection 1.25mg (Unlicensed) Initiation by Consultant Ophthalmologist only
08.03.04.02	Bicalutamide Casodex^®
11.06	Bimatoprost Lumigan^®	Eye drops 300micrograms/ml This is been discontinued and unlikely to be available after August 2015
11.06	Bimatoprost preservative-free Lumigan UD ^®	For patients with hypersensitivity to preservatives Approved by HaRD APC May 2013
11.06	Bimatoprost with Timolol Ganfort^®	Eye drops (Bimatoprost 300micrograms/ml & timolol 0.5%) Use only if patients are non-compliant with the two individual eye drops
12.03.05	BioXtra^®
06.01.01.02	Biphasic Insulin Aspart NovoMix^® 30	Cartridge Flexpen
06.01.01.02	Biphasic Insulin Lispro Humalog^® Mix25	Cartridge Kwikpen
06.01.01.02	Biphasic Insulin Lispro Humalog^® Mix50	Cartridge Kwikpen
06.01.01.02	Biphasic Isophane Insulin Humulin^® M3	Cartridge Kwikpen
01.06.02	Bisacodyl	Suppositories 5mg, 10mg First choice in primary care
02.04	Bisoprolol Fumarate	Tablets 1.25mg, 2.5mg, 5mg First line in heart failure
09.05.01.02	Bisphosphonates
08.01.02	Bleomycin
24.16	Blood Products Neonatal	Not pharmacy products - order from Blood Bank
04.09.03	Botulinum Toxin Type A Botox^®	Injection 100units On the advice of a specialist. Prescribe by brand
04.09.03	Botulinum Toxin Type A Dysport^®	Injection 500units Initiation on the advice of a specialist. Prescribe by brand
04.09.03	Botulinum Toxin Type B NeuroBloc^®
01.06.05	Bowel Cleansing Solutions Moviprep^®	Approved by HaRD Area Prescribing Committee September 2013.
13.06	Brimonidine 0.3% Gel Mirvaso^®	Brimonidine gel will not be effective in inflammatory rosacea i.e. it will not treat papules and pustules. Do not treat erythema associated with rosacea unless the inflammatory component is controlled. If the inflammatory component of rosacea is difficult to manage please refer to secondary care - do not treat with Brimonidine. Brimonidine will not be effective in a proportion of patients. The onset on action is less than an hour in most patients. HDFT Dermatologists practice is to give a test dose, and assess the patient at 1-2 hours. If Brimonidine treatment is judged to be effective by the clinician, it can be prescribed. The patient should be informed that increasing the topical dose to more than the five pea sized applications to the face once daily will NOT improve efficacy and is an off-licence use. Patients should be informed that the product can be used once daily, but it is acceptable to use on a PRN basis. Rebound erythema can occur 5-10 hours post dose which seems to be responsive to further application of Brimonidine (off licence use). Further studies are required to elucidate if this rebound is associated with any long term adverse events.
11.06	Brinzolamide Azopt^®	Eye drops 10mg/ml
11.06	Brinzolamide 1% with Timolol 0.5% (Azarga^®)	Eye drops (Brinzolamide 10mg & timolol 0.5%) For use only if patients are non-compliant with the two individual eye drops
11.06	Brinzolamide 10mg/ml & Brimonidine 2mg/ml Eye Drops Simbrinza^®	Approved by the Area Prescribing Committee, December 2014.
04.08.01	Brivaracetam Briviact^®	Initiation on the advice of a Neurologist
13.05.02	Brodalumab
01.05.02	Budesonide Budenofalk^®	MR Capsules 3mg
03.02	Budesonide	Pulmicort^® Easyhaler^®
03.01	Budesonide and Formoterol Fobumix^®	Each delivered dose (the dose that leaves the mouthpiece) contains: budesonide 160 micrograms/inhalation and formoterol fumarate dihydrate 4.5 micrograms/inhalation.
03.02	Budesonide and formoterol Symbicort^®	Turbohaler budesonide 200micrograms/formoterol 6 micrograms per dose For initiation by repiratory specialists only
24.01	Budesonide nebules
02.02.02	Bumetanide
15.02	Bupivacaine and Adrenaline
15.02	Bupivacaine Hydrochloride
15.02	Bupivacaine hydrochloride Marcain heavy^®
04.07.02	Buprenorphine BuTrans^®	Patches 5micrograms/hr, 10micrograms/hr, 20micrograms/hr Once a week patch Butec is preferred brand in primary care Initiation on the advice of a specialist
04.07.02	Buprenorphine Temgesic^®	Sublingual tablets 0.4mg, 2mg
04.07.02	Buprenorphine Transtec^®	Patches 35micrograms/hr, 52.5micrograms/hr, 70micrograms/hr Change every 96 hours Initiation on the advice of a specialist
04.10	Buprenorphine Subutex^®	Not stocked at HDFT Initiation on the advice of a Consultant Psychiatrist
02.02.04	Burinex A^®	Tablets amiloride/bumetanide 5/1mg
08.01.01	Busulfan Myleran^®
03.04.03	C₁ Esterase Inhibitor Berinert^®
04.09.01	Cabergoline	Tablets 500micrograms Initiation on the advice of a specialist
06.07.01	Cabergoline Dostinex^®	Tablets 500micrograms Initiation on the advice of a specialist
24.16	Caffeine citrate Neonatal
13.03	Calamine	Lotion 200ml
13.05.02	Calcipotriol Dovonex^®
13.05.02	Calcipotriol 50micrograms/g with Betamethasone 0.05% Dovobet^® gel and ointment and Enstilar^® cutaneous foam	When prescribing Dovobet Gel, please prescribe "Dovobet Gel with Applicator". This aids administration to the scalp. Please note that NICE states that Dovobet is a 4th line topical in patients with mild psoriasis that are able to adhere to twice daily treatment. Topical treatment of psoriasis affecting the trunk and limbs 1.3.2.1 Offer a potent corticosteroid applied once daily plus vitamin D or a vitamin D analogue applied once daily (applied separately, one in the morning and the other in the evening) for up to 4 weeks as initial treatment for adults with trunk or limb psoriasis. 1.3.2.2 If once-daily application of a potent corticosteroid plus once-daily application of vitamin D or a vitamin D analogue does not result in clearance, near clearance or satisfactory control of trunk or limb psoriasis in adults after a maximum of 8 weeks[22], offer vitamin D or a vitamin D analogue alone applied twice daily. 1.3.2.3 If twice-daily application of vitamin D or a vitamin D analogue does not result in clearance, near clearance or satisfactory control of trunk or limb psoriasis in adults after 8–12 weeks[22], offer either: a potent corticosteroid applied twice daily for up to 4 weeks or a coal tar preparation applied once or twice daily. 1.3.2.4 If a twice-daily potent corticosteroid or coal tar preparation cannot be used or a once-daily preparation would improve adherence in adults offer a combined product containing calcipotriol monohydrate and betamethasone dipropionate applied once daily for up to 4 weeks.
06.06.01	Calcitonin (salmon) / Salcatonin Miacalic^®	Injection 100 units/ml Initiation on the advice of a specialist
13.05.02	Calcitriol 3micrograms/g Silkis^®
08.01	Calcium Folinate	Injection 50mg/5ml
24.16	Calcium gluconate Neonatal
09.05.01	Calcium Gluconate 10%	Please see link to Hypocalcaemia Guidelines
09.05.01.01	Calcium Salts Calcium Chloride	Minijet 10% (6.8mmol/10ml)
09.05.02.02	Calcium Salts Calcichew^®	Chewable tablets 1.25mg (500mg calcium) Initiation on the advice of a Renal Specialist
09.05.02.02	Calcium Salts Phosex^®	Tablets 1g Initiation on the advice of a Renal Specialist
06.01.02.03	Canagliflozin Invokana^®	Approved by the Area Prescribing Committee September 2014
02.05.05.02	Candesartan Cilexetil Amias^®	Tablets 4mg 8mg 16mg
20	Cantharadin, podophyllin and salicylic acid Cantherone Plus^®	Approved by HaRD Area Prescribing Committee April 2014 for an initial 3 month trial. To be initiated by Consultant Dermatologists only and used if all other treament options have failed.
08.01.03	Capecitabine Xeloda^®
04.07.03	Capsacin	Cream 0.025%, 0.075% For initiation by a specialist
10.03.02	Capsaicin Zacin^®	Cream 0.025%, 0.075% For use by specialist pain team only
24.01	Captopril	Licensed liquid available
04.07.03	Carbamazepine	Tablets 100mg, 200mg Liquid 100mg/5ml
04.08.01	Carbamazepine	Tablets 100mg, 200mg MR tablets 200mg, 400mg Liquid 100mg/5ml Suppositories 125mg, 250mg Prescribe by brand
24.01	Carbamazepine
06.02.02	Carbimazole Neo-Mercazole^®	Tablets 5mg, 20mg
03.07	Carbocisteine	Capsules 375mg Liquid 250mg/5ml Stop after a 4 week trial if no benefit
11.08.01	Carbomer 980 Xailin Gel^®	Eye drops 0.2%
07.01.01	Carboprost Hemabate^®	Injection 250micrograms/ml
11.08.01	Carmellose Sodium 0.5% Xailin Fresh^®
08.01.01	Carmustine BiCNU^®
24.16	Carobel Neonatal
02.04	Carvedilol	Tablets 3.125mg, 6.25mg, 12.5mg For Consultant use only Second line in heart failure
07.04.04	Catheter Patency Solutions Chlorhexidine 0.02%
07.04.04	Catheter Patency Solutions Sodium Chloride 0.9%
07.04.04	Catheter Patency Solutions Solution G
05.01.02.01	Cefaclor	Liquid 250mg/5ml
05.01.02.01	Cefalexin	Capsules 250mg & 500mg Liquid 250mg/5ml
24.01	Cefalexin
05.01.02.01	Cefixime Suprax^®	Tablets 200mg Liquid 100mg/5ml
05.01.02.01	Cefotaxime	Injection 500mg & 1g powder Formulary Indication: Meningitis For all other indications microbiology advice should be sought
24.01	CefoTAXime
24.16	Cefotaxime Neonatal	Cefotaxime for any indication requires microbiology approval, including patients transferred to the unit where cefotaxime has already been initiated
05.01.02.01	Ceftazidime	Injection 1g & 2g powder For use on microbiology advice ONLY Ceftazidime-Avibactam (Zaficefta) also approved for use on microbiology advice ONLY
24.16	Ceftazidime Neonatal
05.01.02.01	Ceftriaxone	Injection 1g Powder Paediatrics ONLY, unless recommended by a consultant microbiologist.
24.01	CefTRIAXone
05.01.02.01	Cefuroxime	Injection 250mg, 750mg & 1.5g powder
11.03.01	Cefuroxime	Intracameral injection 3mg
24.01	CefUROXime
24.16	Cefuroxime Neonatal
10.01.01	Celecoxib Celebrex^®	Capsules 100mg Initiation on the advice of a Consultant Rheumatologist only
10.01.03	Certolizumab Pegol Cimzia^®	Initiation by a Consultant Rheumatologist
03.04.01	Cetirizine	First-line at HDFT Tablets 10mg; Liquid 5mg/5ml
24.01	Cetirizine
08.01.05	Cetuximab Erbitux^®
04.01.01	Chloral Hydrate	Liquid 500mg/5ml Unlicensed
24.01	Chloral hydrate
20	CHLORAL HYDRATE mixture 1g/10ml
08.01.01	Chlorambucil Leukeran^®	Tablets 2mg
05.01.07	Chloramphenicol	Eye drops (0.5%) & ointment (1%) Injection 1g Topical use for conjuctivitis
11.03.01	Chloramphenicol	Eye drops 0.5% Eye ointment 1% Minims 0.5%
24.16	Chloramphenicol Neonatal
04.01.02	Chlordiazepoxide Hydrochloride	For alcohol detoxification only
13.11.02	Chlorhexidine Gluconate 0.5% (Aqueous)
13.11.02	Chlorhexidine Gluconate 0.015% with Cetrimide 0.15% Tisept^®
13.11.02	Chlorhexidine Gluconate 4%	Brands include Hydrex
13.11.02	Chlorhexidine Gluconate Solution 2.5% (≡ Chlorhexidine Gluconate 0.5%) (Alcoholic)
13.11.02	Chlorhexidine Gluconate Solution 5% (≡ Chlorhexidine Gluconate 1%) Hibitane Obstetric^®
12.02.03	Chlorhexidine Hydrochloride 0.1%, Neomycin Suphate 0.5% Naseptin^®	Nasal cream Contains peanut oil
12.03.02	Chlorhexidine Mouthwash	Mouthwash 0.2% Mint flavour
24.16	Chlorothiazide Neonatal
24.01	Chlorphenamine
03.04.01	Chlorphenamine Maleate	Tablets 4mg; Liquid 2mg/5ml; Injection 10mg/ml
04.02.01	Chlorpromazine Hydrochloride	Tablets 10mg, 25mg, 50mg, 100mg Injection 50mg/2ml (hospital only) Liquid 100mg/5ml
02.02.01	Chlortalidone
12.03.01	Choline Salicylate Bonjela^® Adult
08.02.02	Ciclosporin	Due to differences in bioavailability, patients must remain on the same brand of immunosuppressant except on the advice of specialist clinician. MUST be prescribed by brand.
10.01.03	Ciclosporin	Capsules 25mg, 50mg, 100mg Due to differences in bioavailability, patients must remain on the same brand of immunosuppressant except on the advice of specialist clinician. MUST be prescribed by brand.
13.05.03	Ciclosporin	Due to differences in bioavailability, patients must remain on the same brand of immunosuppressant except on the advice of specialist clinician. MUST be prescribed by brand.
11.08.01	Ciclosporin 1mg/mL Eye Drops Ikervis^®	Approved in line with NICE TA369
09.05.01.02	Cinacalcet Mimpara^®	Tablets 30mg, 90mg For use by the Renal Unit only
05.01.12	Ciprofloxacin	Tablets 250mg Infusion 200mg/100ml & 400mg/200ml (hospital only) Approved Indications: Complicated UTIs Pyelonephritis (2nd Line) Urinary Sepsis (2nd Line) Severe Salmonella/Campylobacter Severe Otitis Externa Prostatitis Human/Animal Bites Micobiology advice should be sought for all other indications
08.01.05	Cisplatin
04.03.03	Citalopram	Tablets 10mg, 20mg Oral drops 40mg/ml (8 oral drops = 10mg tablet)
01.06.05	Citrafleet^®
20	Citric acid 0.6mol/5ml	Approved by HaRD APC for the assessment of laryngeal sensation via Cough Reflex Testing (CRT) in patients admitted with stroke with a known or suspected swallowing impairment
08.01.03	Cladribine Litak^®
08.01.03	Cladribine
05.01.05	Clarithromycin	Tablets 250mg Liquid 125mg/5ml Injection 500mg powder (hospital only)
24.01	Clarithromycin	Oral - BNFc IV - follow prescribing and administration guide
24.16	Clarithromycin Neonatal
05.01.06	Clindamycin	Capsules 150mg Liquid 75mg/5ml (Unlicensed) Injection 300mg/2ml
24.01	Clindamycin	Suspension is unlicensed
13.06.01	Clindamycin 1% Dalacin T^®
04.08.01	Clobazam	Tablets 10mg Initiation on the advice of a Neurologist
13.04	Clobetasol Propionate 0.05% Dermovate^®	Cream 30g, 100g Ointment 30g, 100g
13.04	Clobetasone Butyrate 0.05% Eumovate^®	Cream 30g Ointment 30g
13.04	Clobetasone Butyrate 0.05%, Oxytetracycline 3%, Nystatin 100,000 units/g Trimovate^®
06.05.01	Clomifene Citrate Clomid^®	Tablets 50mg
04.08.01	Clonazepam Rivotril^®	Tablets 500micrograms Initiation on the advice of a Neurologist
04.08.02	Clonazepam Rivotril^®	Injection 1mg/ml
24.01	Clonidine (growth hormone stimulation test)
02.09	Clopidogrel	Tablets 75mg
07.02.02	Clotrimazole	Cream 1% Solution 1% Pessaries 200mg, 500mg
12.01.01	Clotrimazole Canesten^®	Cream 1%
13.10.02	Clotrimazole	Cream and Solution
04.02.01	Clozapine Clozaril^®	Tablets 25mg, 100mg Initiation by specialists only. Patients must be registered with Clozaril monitoring service.
13.05.02	Coal Tar 10% Carbo-Dome^®
13.05.02	Coal Tar in Lassars Paste
13.05.02	Coal Tar Solution 12%, Salicylic Acid 2%, Precipitated Sulphur 4% Sebco^®
13.05.02	Coal Tar Solution 2.5%, Arachis (peanut) Oil extract of Coal Tar 7.5%, Tar 7.5%, Cade Oil 7.5%, Liqiud Paraffin 35% Polytar Emollient^®
02.02.04	Co-amilofruse (furosemide and amiloride)	Tablets amiloride/furosemide 2.5/20mg, 5/40mg
05.01.01.03	Co-Amoxiclav	Tablets 375mg & 625mg Syrup 125/31mg & 250/62mg Injection 1.2g powder Should be prescribed as "Amoxicillin/Clavulanate" to identify it as a penicillin. Indications Animal/Human Bites Open fractures
24.01	Co-amoxiclav	Oral - follow BNFc IV - follow dosing and administration guide
24.16	Co-amoxiclav Neonatal	Oral dosing for chest infections in neonates without IV access (providing there have been no previous resistant gram negative bacteria isolated): dose as per BNFc (click icon to the left). When prescribed ensure the concentration (125/31) is clearly written on the prescription. IV dosing on the recommendation of microbiology only: dose as per BNFc (click icon to the left), administration as per Paediatric Medusa IV Guide (see link below)
04.09.01	Co-Beneldopa Madopar^®	Benserazide/levodopa Capsules 12.5/50, 25/100, 50/200 Dispersible tablets 12.5/50, 25/100 MR capsules 25/100
04.09.01	Co-Beneldopa Madopar^®CR
15.02	Cocaine
04.09.01	Co-Careldopa Sinemet^®	Carbidopa/levodopa Tablets 10/100, 12.5/50, 25/100, 25/250 MR tablets 25/100, 50/200
04.09.01	Co-Careldopa Half Sinemet ^®CR
04.09.01	Co-Careldopa Sinemet^® CR
04.09.01	Co-Careldopa and Entacapone Sastravi^®
13.06.02	Co-Cyprindiol 2000/35 (Cyproterone Acetate 2mg with Ethinylestradiol 35micrograms) Dianette^®
01.06.02	Co-danthramer	Suspension 25/200 in 5ml; Strong suspension 75/1000 in 5ml For palliative patients only
01.06.02	Co-danthrusate	Capsules 50/60
03.09.01	Codeine Linctus BP	Liquid 15mg/5ml
01.04.02	Codeine Phosphate	Tablets 15mg 30mg
04.07.02	Codeine Phosphate	Tablets 15mg, 30mg Liquid 15mg/5ml Injection 60mg/ml - CONTROLLED DRUG
04.07.02	Codeine Phosphate Codeine Linctuses	Liquid 15mg/5ml
10.01.04	Colchicine	Tablets 500 micrograms
24.16	Colecalciferol Neonatal	3000units/ml oral solution (unlicensed)
09.06.04	Colecalciferol (vitamin D3)
09.06.04	Colecalciferol and Calcium Carbonate Adcal-D3^®
02.12	Colesevelam Cholestagel®	management of bile acid malabsorption
01.09.02	Colestyramine	Sachets 4g
05.01.07	Colistin Colomycin^®	Approved by the Area Prescribing Committee for non-cystic fibrosis bronchiectasis
10.03.01	Collagenase clostridium histolyticum Xiapex^®
01.01.01	Co-magaldrox Maalox^®
07.03.01	Combined Hormonal Contraceptives Millinette20/75^®	Ethinylestradiol 20micrograms/gestodene 75 micrograms Approved by HaRD Area Prescribing Committee June 2014
07.03.01	Combined Hormonal Contraceptives Mercilon/Gedarel 20/150^®	Tablets ethinyestradiol 20micrograms/ desogestrel 150micrograms
07.03.01	Combined Hormonal Contraceptives Evra^®	Patch ethinylestradiol 33.9micrograms/24hours & norelgestromin 203micrograms/24hours
07.03.01	Combined Hormonal Contraceptives Logynon^®	Tablets
07.03.01	Combined Hormonal Contraceptives Microgynon 30^® Rigevidon ^® Levest^®	Tablets Ethinylestradiol 30micrograms/ levonorgestrel 150micrograms
07.03.01	Combined Hormonal Contraceptives Cilest^®	Tablets ethinylestradiol 35micrograms, norgestimate 250micrograms
07.03.01	Combined Hormonal Contraceptives Marvelon/Gedarel 30/150^®	Tablets ethinylestradiol 30micrograms/ desogestrel 150micrograms
07.03.01	Combined Hormonal Contraceptives Yasmin^® Lucette ^®	Tablets Ethinylestradiol 30micrograms/ drospirenone 3mg
07.03.01	Combined Hormonal Contraceptives Femodene^®	Tablets Ethinylestradiol 30micrograms / gestodene 75micrograms
06.01.06	Contour Black Edition meter
01.04.02	Co-Phenotrope Lomotil^®	Tablets
05.01.08	Co-trimoxazole	(Trimethoprim/sulfamethoxazole) Tablets 480mg & 960mg Injection 480mg/5ml
13.03	Crotamiton Eurax/Eurax HC^®	Cream 10% (30g) With hydrocortisone 2.5% (30g)
04.06	Cyclizine	Tablets 50mg Injection 50mg/ml
17	Cyclizine	Dose: 50mg s/c every 8 hours prn
24.16	Cyclopentolate 0.5% eye drops Neonatal
11.05	Cyclopentolate Hydrochloride	Eye drops 0.5%, 1%
11.05	Cyclopentolate Hydrochloride single use Minims^® Cyclopentolate Hydrochloride	Eye drops 1%
08.01.01	Cyclophosphamide	Tablets 50mg
06.04.02	Cyproterone Acetate	Tablets 100mg Initiation on the advice of a specialist
08.03.04.02	Cyproterone Acetate	Tablets 100mg
08.01.03	Cytarabine
02.08.02	Dabigatran Pradaxa^®	See NICE guidance. NOAC of choice in patients requiring cardioversion. Dabigatran and edoxaban will be reserved for those who have a contra-indication to, or intolerant of rivaroxaban / apixaban or where the prescriber feels dabigatran or edoxaban would be the most appropriate agent.
08.01.05	Dabrafenib Tafinlar^®	Patients are referred to Leeds Teaching Hospitals
06.07.02	Danazol	Capsules 100mg, 200mg Initiation on the advice of a specialist
10.02.02	Dantrolene Sodium Dantrium^®	Capsules 25mg, 100mg Injection 20mg
15.01.08	Dantrolene Sodium Dantrium Intravenous^®
06.01.02.03	Dapagliflozin Forxiga^®
05.01.07	Daptomycin Cubicin^®	For use on microbiology advice ONLY
08.01.05	Dasatinib Sprycel^®
08.01.02	Daunorubicin
09.01.03	Deferasirox Exjade^®	Dispersible tablets 125mg, 250mg, 500mg Initiation by Consultant Haematologist only
09.01.03	Deferiprone Ferriprox^®	Tablets 500mg Initiation by Consultant Haematologist only
08.03.04.02	Degarelix Firmagon^®	Approved by the Area Prescribing Committee, December 2014
06.06.02	Denosumab Prolia^®	Initiation in accordance with shared care guidelines
09.01.03	Desferrioxamine Mesilate Desferal^®	Injection 500mg
15.01.02	Desflurane Suprane^®
06.05.02	Desmopressin	Tablets 200micrograms (Desmotabs) Nasal spray 10 micrograms/dose (Desmospray) Sublingual tablets 120 micrograms(Desmomelt) Intravenous injection 4 micrograms/mL Subcutanous injection 15 micrograms/mL (Octim) Initiation on the advice of a specialist
24.01	Desmopressin
06.03.02	Dexamethasone	Tablets 500micrograms, 2mg Injection 3.3mg base(4mg/ml as sodium phosphate) Injection 6.6mg base (8mg/2ml as sodium phosphate)
11.04.01	Dexamethasone Maxidex^®	Eye drops 0.1%
11.04.01	Dexamethasone Minims^® Dexamethasone	Eye drops 0.1%
11.04.02	Dexamethasone Ozurdex^®	Intra-vitreal implant 700micrograms
24.01	Dexamethasone
24.16	Dexamethasone Neonatal
12.01.01	Dexamethasone with Antibacterial Otomize^®	Ear spray (dexamethasone 0.1%, neomycin 3250 units/ml, glacial acetic acid 2%)
11.04.01	Dexamethasone with Neomycin and Polymyxin B sulphate maxitrol^®	Eye drops
17	Diamorphine	First choice opiate in normal renal function
24.01	Diamorphine
04.07.02	Diamorphine Hydrochloride	Injection 5mg, 10mg, 30mg, 100mg Intranasal spray (Ayendi^®)
04.01.02	Diazepam	Tablets 2mg, 5mg, 10mg Liquid 2mg/5ml
04.08.02	Diazepam	Rectal solution 5mg/2.5ml, 10mg/2.5ml Injection 10mg/2ml Emulsion injection 10mg/2ml
04.08.03	Diazepam	Rectal solution 5mg/2.5ml, 10mg/2.5ml Injection 10mg/2ml (hospital only)
10.02.02	Diazepam	Tablets 2mg, 5mg, 10mg Liquid 2mg/5ml
24.01	Diazepam
10.01.01	Diclofenac Sodium	Tablets EC 25mg, 50mg MR tablets 75mg, 100mg Dispersible tablets 50mg Suppositories 12.5mg, 50mg, 100mg Gel 1%
10.01.01	Diclofenac Sodium Voltarol^®	Injection 75mg/3ml
13.08.01	Diclofenac Sodium Solaraze^®	Second line
08.03.01	Diethylstilbestrol
24.01	Diethylstilboestrol (pre-pubertal priming)	See individual protocols for clonidine and glucagon stimulation tests
02.01.01	Digibind
02.01.01	Digoxin
04.07.02	Dihydrocodeine Tartrate	Tablets 30mg Liquid 10mg/5ml Injection 50mg/ml - CONTROLLED DRUG
01.07.04	Diltiazem Cream 2%	Unlicensed
02.06.02	Diltiazem Hydrochloride Tildiem^®	MR tablets (SR) 60mg, 90mg, 120mg (twice daily dosing) MR capsules (LA) 200mg, 300mg (once daily dosing) Prescribe by brand
02.06.02	Diltiazem Hydrochloride Adizem^®	SR Capsules 90mg, 120mg, 180mg (twice daily dosing) XL Capsules 120mg, 180mg, 240mg, 300mg (once daily dosing) Prescribe by brand
02.06.02	Diltiazem Hydrochloride Adizem-SR^®	MR Capsules 90mg, 120mg, 180mg Prescribe by brand
02.06.02	Diltiazem Hydrochloride Dilzem^® SR	MR Capsules (SR) 60mg (twice daily dosing) Prescribe by brand
13.05.02	Dimethyl Fumarate Skilarence^®
20	DIMETHYL SULPHOXIDE Bladder Instillation 50%
13.10.04	Dimeticone Hedrin^®
07.01.01	Dinoprostone Prostin E2^®	Vaginal gel 1mg/2.5ml, 2mg/2.5ml Extra-amniotic solution 5mg/0.5ml
07.01.01	Dinoprostone Propess^®	Pessaries 10mg
14.04	Diphtheria, Tetanus, Pertussis (Acellular, Component), Poliomyelitis (Inactivated) and Haemophilus Type b Conjugate Vaccine (Adsorbed), Hepatitis B (Infanrix Hexa®)
24.16	Diphtheria, Tetanus, Pertussis (Acellular, Component), Poliomyelitis (Inactivated) and Haemophilus Type b Conjugate Vaccine (Adsorbed), Hepatitis B (Infanrix Hexa®) Neonatal
02.09	Dipyridamole Persantin^® Retard	MR capsules 200mg
02.09	Dipyridamole and Aspirin Asasantin^® Retard	MR capsules aspirin/dipyridamole 25/200mg
06.06.02	Disodium Pamidronate	Injection 30mg
02.03.02	Disopyramide	MR Tablets 250mg; Capsules 100mg; Injection 50mg/5ml (hospital only)
04.10	Disulfiram Antabuse^®	Tablets 200mg Initiation on the advice of a Psychiatrist
13.05.02	Dithranol Dithrocream^®
20	DITHRANOL 0.1% /0.25%,0.5%,1%,2%,4%in lassars paste
02.07.01	Dobutamine	Injection 250mg/20ml
24.01	Dobutamine
24.16	Dobutamine Neonatal
04.06	Domperidone	Tablets 30mg Liquid 5mg/5ml Suppositories 30mg
04.11	Donepezil Hydrochloride Aricept^®	Tablets 5mg, 10mg Initiation on the advice of a specialist
24.01	Dopamine
24.16	Dopamine Neonatal
02.07.01	Dopamine Hydrochloride	Injection 200mg/5ml, 800mg/20ml
03.07	Dornase Alfa Pulmozyme^®	Nebuliser solution 2.5mg/2.5ml For cystic fibrosis patients only
11.06	Dorzolomide Trusopt^®	Eye drops 2%
11.06	Dorzolomide 2% with Timolol 0.5% Cosopt^®	Eye drops (Dorzolamide 2% & timolol 0.5%)
15.01.07	Doxapram Hydrochloride Dopram^®
02.05.04	Doxazosin	Tablets 1mg, 2mg, 4mg
13.04	Doxepin Hydrochloride Xepin^®
08.01.02	Doxorubicin Hydrochloride
05.01.03	Doxycycline	Capsules 100mg Dispersible tablets 100mg
12.03.01	Doxycycline
12.03.02	Doxycycline	Dispersible tablets 100mg (unlicensed indication) Use as a mouthwash (third line option after chlorhexidine mouthwash and betamethasone soluble tablets used as a mouthwash)
02.03.02	Dronedarone Multaq^®	For use by Cardiology Specialists only if intolerant to amiodarone
04.06	Droperidol Xomolix^®	Injection 2.5mg/ml On the advice of a specialist
03.01.05	Drug Delivery Device Haleraid^®	120 dose, 200 dose
03.01.05	Drug Delivery Device Volumatic^®	Standard Standard with mask
03.01.05	Drug Delivery Device AeroChamber^®	Child with mask (yellow) Infant with mask (orange) Standard (blue) Standard with mask (blue)
06.01.02.03	Dulaglutide Trulicity^®	Approved by the Area Prescribing Committee (July 2015) in line with NICE criteria. Seek advice from the Specialist Diabetes Team where GLP-1 is being added with insulin in Type-2 diabetes (Amber).
04.03.04	Duloxetine Cymbalta^®	Capsules 30mg, 60mg Only on the advice of a specialist. Specify brand
24.01	Duocal Super Soluble Powder	Paediatric Nutritional Products List - approved APC 05/18
13.05.03	Dupilumab Dupixent^®	For use by Consultant Dermatologists only - for the treatment of moderate-to-severe atopic dermatitis in adult patients who are candidates for systemic therapy.
02.08.02	Edoxaban Lixiana^®	Dabigatran and edoxaban will be reserved for those who have a contra-indication to, or intolerant of rivaroxaban / apixaban or where the prescriber feels dabigatran or edoxaban would be the most appropriate agent.
10.02.01	Edrophonium Chloride	Injection 10mg/ml
15.01.06	Edrophonium Chloride
13.09	Eflornithine Vaniqa^®	For Dermatology and Endocrinology
24.01	Elemental 028 Extra Liquid	Paediatric Nutritional Products List - approved APC 05/18
24.01	Elemental 028 Extra Powder	Paediatric Nutritional Products List - approved APC 05/18
24.16	Elfin Trial Neonatal
09.01.04	Eltrombopag Revolade^®	Approved in line with NICE TA293
01.04.02	Eluxadoline Truberzi
13.02.01	Emollient Imuderm^®
13.02.01.01	Emollient Bath Additive Zerolatum^®
13.02.01	Emollient preparation zerocream^®	50g
13.02.01	Emollient preparation Zerobase^®	Tube 50g Pump dispenser 500g
13.02.01	Emollient preparation Zeroderm^®	Ointment 500g
13.02.01	Emollient preparation Cetraben^®
13.02.01	Emollient preparation containing Urea 10% Flexitol^®	Flexitol or cheapest equivalent
13.02.01	Emollient preparation containing Urea 5% Imuderm^®
13.02.01	Emollient preparation with antimicrobials Dermol 500^®	Lotion 500ml Use under specialist advice only. Linked to Wound Dressing Guideline 05/18
06.01.02.03	Empagliflozin Jardiance^®	Approved by the HaRD Area Prescribing Committee, April 2015, in line with NICE TA336
02.08.01	Enoxaparin Sodium 100mg in 1mL and 150mg in 1mL	Pre-filled syringe 20mg, 40mg, 60mg, 80mg, 100mg, 120mg, 150mg For therapeutic dosing when CrCl is <30ml/min
04.09.01	Entacapone Comtess^®	Tablets 200mg
08.03.04.02	Enzalutamide Xtandi^®
12.02.02	Ephedrine Hydrochloride	Nose drops 0.5%
02.07.02	Ephedrine Hydrocloride	Injection 30mg/ml; Pre-filled syringe 30mg/10ml
08.01.02	Epirubicin hydrochloride
02.02.03	Eplerenone Inspra^®	Initiation by Cardiology specialists only. Patients to be switched to spironolactone 25mg daily by GP after 28 days of treatment with eplerenone.
09.01.03	Epoetin alfa Eprex^®
02.09	Eptifibatide Integrilin^®	Injection 20mg/10ml Infusion 75mg/100ml
09.06.04	Ergocalciferol	Injection 300,000 units
07.01.01	Ergometrine Maleate Ergometrine	Injection 500micrograms/ml
07.01.01	Ergometrine Maleate and Oxytocin Syntometrine^®	Injection ergometrine 500micrograms & oxytocin 5units/ml
08.01.05	Erlotinib Tarceva^®
05.01.02.02	Ertapenem Invanz^®	Microbiology advice only
05.01.05	Erythromycin	Tablets 250mg
24.01	Erythromycin
24.16	Erythromycin Neonatal	Oral dose and administration (GORD): BNF-c
13.06.01	Erythromycin 40mg with Zinc Acetate 12mg/mL Zineryt^®
02.04	Esmolol Hydrochloride Brevibloc^®	Injection 10mg/ml
10.01.03	Etanercept Enbrel^®	Initiation by Consultant Rheumatologists only
10.01.03	Etanercept Benepali	Initiated by consultant rheumatologist or dermatologist only.
13.05.03	Etanercept Benapali^®	Initiation by a consultant Dermatologist only
13.05.03	Etanercept Enbrel ^®	Initiation by consultant Dermatologist only
06.06.01	Etelcalcetide Parsabiv
05.01.09	Ethambutol Hydrochloride Ethambutol^®
02.13	Ethanolamine Oleate	Injection 5%
04.08.01	Ethosuximide	On specialist recommendation only in line with NICE guidance
15.02	Ethyl Chloride Cryogesic^® Spray
15.01.01	Etomidate Hypnomidate^®
08.01.04	Etoposide
10.01.01	Etoricoxib Arcoxia^®	Tablets 30mg, 60mg, 90mg Initiation on the advice of a Consultant Rheumatologist only
20.01	Evolocumab Repatha^®	Secondary prevention high risk/ v high risk with LDL above 4 and in primary prevention (FH) with LDL > 5
08.03.04.01	Exemestane Aromasin^®	Tablets 25mg
06.01.02.03	Exenatide Byetta^®	Pre-filled pen 5-micrograms/dose, 10micrograms/dose Seek advice from the Specialist Diabetes Team where GLP-1 is being added with insulin in Type-2 diabetes (Amber).
06.01.02.03	Exenatide Prolonged Release Bydureon^®	Injection 2mg Seek advice from the Specialist Diabetes Team where GLP-1 is being added with insulin in Type-2 diabetes (Amber). For use in patients with compliance problems with daily injections.
02.12	Ezetimibe Ezetrol^®	Tablets 10mg
10.01.04	Febuxostat Adenuric^®	Tablets 80mg
02.12	Fenofibrate	Tablets 160mg
04.07.02	Fentanyl	Patches 12micrograms/hr, 25micrograms/hr, 50micrograms/hr, 75micrograms/hr, 100micrograms/hr Mezolar is the preferred brand patch in primary care. Injection 100micrograms/2ml, 500micograms/10ml Hodspital only). Nasal spray (PecFent) approved as a Green Drug for patients who have failed all other options.
15.01.04.03	Fentanyl
24.01	Fentanyl
24.16	Fentanyl Neonatal	10microgram/ml injection (unlicensed)
09.01.01.01	Ferrous Fumarate Fersaday^®	Tablets 322mg (100mg iron) Formulary switch from ferrous sulphate
05.01.07	Fidaxomicin DIFICLIR^®	Approved for use after recommendation from Microbiology
09.01.06	Filgrastim Zarzio^®	Pre-filled syringe 300 micrograms/0.5ml 480 micrograms/0.5ml
06.04.02	Finasteride Proscar^®	Tablets 5mg
A5.03.04	Flaminal Forte Gel	On specialist advice only. Wards to order from Pharmacy for each individual patient. For moderate-heavy exudate. Available as 15g
A5.03.04	Flaminal Hydro Gel	On specialist advice only. Wards to order from Pharmacy for each individual patient. For low-medium exudate. Available as 15g
02.03.02	Flecainide Acetate	Tablets 100mg; Injection 150mg/5ml (hospital only)
13.04	Flucinolone Acetonide 0.0025% Synalar 1 in 10 Dilution^®
13.04	Flucinolone Acetonide 0.00625% Synalar 1 in 4 Dilution^®
13.04	Flucinolone Acetonide 0.025% Synalar^®
05.01.01.02	Flucloxacillin	Capsules 250mg & 500mg Syrup 125mg/ml & 250mg/5ml Injection 500mg & 1g powder
24.01	Flucloxacillin	Oral - follow BNFc IV - follow dosing and administration guide
24.16	Flucloxacillin Neonatal
07.02.02	Fluconazole	Capsules 50mg Suspension 50mg/5ml
24.01	Fluconazole
24.16	Fluconazole Neonatal
08.01.03	Fludarabine Phosphate Fludara^®
06.03.01	Fludrocortisone Acetate Florinef^®	Tablets 100micrograms
13.04	Fludroxycortide Haelan^®
24.01	Fluids intravenous
24.16	Fluids intravenous Neonatal	'Standard' solutions containing calcium are no longer used
15.01.07	Flumazenil
24.16	Flumazenil Neonatal
12.01.01	Flumetasone Pivalate 0.02% with Clioquinol 1% Locorten-Vioform^®	Ear drops
11.04.01	Fluocinolone acetonide Iluvien ^®	Intravitreal implant Approved by HaRD Area Prescribing Committee (APC) February 2014 in line with NICE guidance
11.08.02	Fluorescein Sodium Minims^®	Minims 2%
11.04.01	Fluorometholone FML^®	Eye drops Fluorometholone 0.1% & Polyvinyl alcohol 1.4%
08.01.03	Fluorouracil
13.08.01	Fluorouracil Efudix^®
04.03.03	Fluoxetine	Capsules 20mg Liquid 20mg/5ml
04.02.02	Flupentixol Decanoate Depixol^®	Injection 12.5mg/0.5ml, 20mg/ml, 25mg/ml, 40mg/2ml, 50mg/0.5ml, 100mg/ml
04.02.02	Fluphenazine Decanoate	Injection 50mg/0.5ml, 100mg/ml
08.03.04.02	Flutamide
03.02	Fluticasone and formeterol Flutiform	Metered dose inhaler
03.02	Fluticasone and salmeterol Sirdupla^®	Accuhaler (dry powder inhaler) -fluticasone 100 micrograms/salmeterol -fluticasone 250 micrograms/salmeterol -fluticasone 500 micrograms/salmeterol Evohaler (metered dose inhaler) -fluticasone 50 micrograms/salmeterol -fluticasone 125 micrograms/salmeterol -fluticasone 250 micrograms/salmeterol Please note that the Seretide brand of inhalers are only approved for use in children.
12.02.01	Fluticasone furoate Avamys^®	Nasal spray 27.5micrograms/metered spray Initiation by ENT and Respiratory Consultants only.
03.01	fluticasone furoate, umeclidinium bromide and vilanterol Trelegy Ellipta ^®	Each single inhalation provides a delivered dose (the dose leaving the mouthpiece) of 92 micrograms fluticasone furoate, 65 micrograms umeclidinium bromide equivalent to 55 micrograms umeclidinium and 22 micrograms vilanterol (as trifenatate).
12.02.01	Fluticasone Propionate Flixonase/Nasofan^®	Aqueous nasal spray 50micrograms/metered spray
03.02	Fluticasone/Vilanterol Relvar Ellipta^®	Relvar Ellipta 92 micrograms/22 micrograms inhalation powder
03.02	Fluticasone/Vilanterol Relvar Ellipta^®	Relvar Ellipta 184 micrograms/22 micrograms inhalation powder
09.01.02	Folic Acid	Tablets 5mg Liquid 2.5mg/5ml
24.16	Folic acid Neonatal	2.5mg/5ml liquid
02.08.01	Fondaparinux Sodium Arixtra^®	Pre-filled syringe 5mg/ml For use in acute coronary syndromes
24.01	Forceval Junior	Approved by APC 05/18 for use by prescribers following: GUIDELINES FOR THE IN-PATIENT MANAGEMENT OF PAEDIATRIC PATIENTS WITH EATING DISORDERS (UNDER 16 YEARS) See link
03.01.04	Formoterol / aclidinium Duaklir® Genuair	Licensed for COPD only
03.01.01.01	Formoterol Fumarate Easyhaler^®	12 micrograms/metered inhalation
24.01	Fortini	Paediatric Nutritional Products List - approved APC 05/18
24.01	Fortini Compact Multifibre	Paediatric Nutritional Products List - approved APC 05/18
04.06	Fosaprepitant Ivemend^®	Injection 150mg Prescribed on the advice of a specialist only pre-chemotherapy
20	Fosfomycin 2g Injection Fomicyt^®	Approved by the HaRD Area Prescribing Committee, April 2015. To be prescribed on the advice of Microbiology only.
20	FOSFOMYCIN Sachets 3 g	Initiation on the advice of a Microbiologist
06.01.06	FreeStyle Optium Neo Meter
02.11	Fresh Frozen Plasma	Available from Haematology
08.03.04.01	Fulvestrant Faslodex^®	Injection 50mg/ml
02.02.02	Furosemide	Long-term supply problem with furosemide 500mg - switch to bumetanide
24.01	Furosemide
24.16	Furosemide Neonatal
11.03.01	Fusidic Acid Fucithalmic^®	Eye drops MR 1%
13.10.01.02	Fusidic Acid 2% Fucidin^®
04.07.03	Gabapentin	Capsules 100mg, 300mg, 400mg Liquid 250mg/5ml - reserve for patients with long-term swallowing difficulty or long-term feeding tubes.
04.08.01	Gabapentin	Capsules 100mg, 300mg, 400mg
04.11	Galantamine Reminyl^® XL	MR capsules 8mg, 16mg, 24mg Initiation on the advice of a specialist for patients intolerant to donepezil. MR formulation for patients non-compliant with standard release formulation.
04.11	Galantamine	Tablets 12mg Liquid 4mg/ml Initiation on the advice of a specialist for patients intolerant to donepezil
11.03.03	Ganciclovir 0.15% Virgan^®
01.01.02	Gaviscon Infant	Sachets
08.01.05	Gefitinib Iressa^®
08.01.03	Gemcitabine Gemzar^®
07.01.01	Gemeprost	Pessary 1mg For miscarriage if mifepristone & misoprostol have failed. Discuss with Consultant in Obs&Gynae before prescribing.
05.01.04	Gentamicin	Injection 20mg/2ml & 80mg/2ml
11.03.01	Gentamicin	Eye drops 0.3%
24.01	Gentamicin
24.16	Gentamicin Neonatal
12.01.01	Gentamicin 0.3% with Hydrocortisone Acetate 1% Gentisone^® HC
01.07.01	Germaloids^®	Cream; Ointment; Suppositories
12.03.05	Glandosane^®	Aerosol spray
06.01.02.01	Glibenclamide	Tablets 2.5mg, 5mg Initiation on the advice of a specialist
06.01.02.01	Gliclazide	Tablets 80mg MR tablets 30mg - Initiation on the advice of a specialist. NB: Gliclazide and gliclazide MR doses are not bioequivalent. Contact a diabetes specialist for advice
06.01.02.01	Glimepiride	Tablets 1mg Initiation on the advice of a specialist
06.01.04	Glucagon GlucaGen^® HypoKit	Injection 1mg
24.01	Glucagon
06.01.04	Glucojuice Glucojuice	Approved by the Area Prescribing Committee March 2017
06.01.06	GlucoMen LX beta-ketone
06.01.06	GlucoMen LX Plus meter
06.01.06	GlucoRx HCT & Ketone meter
06.01.06	GlucoRx Nexus meter
06.01.04	Glucose	Tablets Injection 50%
06.01.04	Glucose gel Glucogel	Oral gel 40% (3x25g)
09.02.02.01	Glucose Intravenous	5% (100ml, 250ml, 500ml, 1000ml)) 10% (500ml) 12.5% (250ml) 15% (500ml) 20% (500ml) 50% (500ml)
06.01.06	GluNeo meter
01.06.02	Glycerol (Glycerin)	Suppositories 1g 2g 4g
02.06.01	Glyceryl Trinitrate	Spray 400micrograms/dose; Buccal tablets 2mg, 3mg, 5mg; Sublingual tablets 500micrograms; Injection 50mg/50ml (hospital only)
20	Glyceryl Trinitrate 0.4% Ointment Rectogesic^®	Approved by HaRD APC March 2017 for chondrodermatitis
07.04.04	Glycine	Irrigation solution 1.5% 3L
15.01.03	Glycopyrronium Bromide (Glycopyrrolate) Robinul^®
13.12	Glycopyrronium Bromide tablets	This is an UNLICENSED medicine
01.05.03	Golimumab Simponi
06.07.02	Goserelin	Injection 3.6mg, 10.8mg Initiation on the advice of a specialist Not stocked at HDFT
08.03.04.01	Goserelin Zoladex^®	Implant 3.6mg
08.03.04.02	Goserelin Zoladex^®
04.06	Granisetron 3.1mg/24 hour patches Sancuso^®	Approved for an initial 6 month trial. Usage to be reviewed by the Area Prescribing Committee in July 2014
03.04.02	Grass and Tree Pollen Extract Pollinex^®	For immunotherapy Consultant use only
03.04.02	Grass pollen extract Grazax^®	For immunotherapy Consultant use only
13.05.03	Guselkumab	Added as NICE TA521 available - see link Not yet approved by the APC
14.04	Haemophilus influenzae type B
04.02.01	Haloperidol	Tablets 1.5mg, 5mg, 10mg, 20mg Capsules 500 micrograms Liquid 2mg/ml Injection 5mg/ml
04.02.02	Haloperidol Haldol Decanoate^®	Injection 50mg/ml, 100mg/ml
17	Haloperidol	Dose: 0.5mg - 2.5mg s/c every 6 hours prn max 10mg/24hrs
13.02.01	Heel Balm (Urea 25%) Flexitol^®	Approved by HaRD Area Prescribing Committee June 2017. Initiated in the diabetic foot clinic only. Treatment stopped after 4 weeks if no benefit observed.
24.01	Heparin (unfractionated)
24.16	Heparinised saline Neonatal
13.13	Heparinoid 0.3% Hirudoid^®
14.04	Hepatitis A vaccine
14.05.02	Hepatitis B immunoglobulin
14.04	Hepatitis B vaccine
24.16	Hepatitis B vaccine and immunoglobulin Neonatal	Dose: BNF-c
20	HRH Cream Pigmanorm^®	Approved by the Area Prescribing Committee, April 2016 Prescriptions for all other strengths of HRH should be queried; agreed in Dermatology Quality of Care to only prescribe and dispense the 5% Pigmanorm preparation
09.02.02.02	Human Albumin Solution	Obtain from Haematology
20	Human chorionic gonadotrophin (ULM)	Approved by HaRD Area Prescribing Committee January 2019 for male fertility
10.03.01	Hyaluronidase Hyalase^®	Injection 1500 units
02.05.01	Hydralazine Hydrochloride	Injection 20mg
01.05.02	Hydrocortisone Colifoam^®	125mg /metered application
06.03.02	Hydrocortisone Hydrocortisab^®	Hydrocortisone acetate 25mg/ml injection
06.03.02	Hydrocortisone Solu-Cortef^®	Hydrocortisone sodium succinate 100mg injection
24.16	Hydrocortisone Neonatal
13.04	Hydrocortisone 0.25% Crotamiton 10% Eurax-Hydrocortisone^®
13.04	Hydrocortisone 0.5%, nystation 100,000 units/g Benzalkonium Chloride Solution 0.2%, Dimeticone 350 10% Timodine^®
13.04	Hydrocortisone 1% with Clotrimazole 1% Canesten HC^®
13.04	Hydrocortisone 1% with Miconazole Nitrate 2% Daktacort^®
10.01.02.02	Hydrocortisone acetate Hydrocortistab^®	Injection 25mg/ml
13.04	Hydrocortisone Acetate 1% with Fusidic Acid 2% Fucidin H^®
12.01.01	Hydrocortisone Acetate 1% with Gentamicin 0.3% Gentisone^® HC	Eye/Ear drops
13.04	Hydrocortisone cream	0.5%, 1% and 2.5%
24.01	Hydrocortisone cream/ointment
24.01	Hydrocortisone injection
13.11.06	Hydrogen Peroxide 1% cream Crystacide^®
20	Hydroquinone 4% cream	Approved for one patient only, May 2016
09.01.02	Hydroxocobalamin	Injection 1mg/ml
08.01.05	Hydroxycarbamide
10.01.03	Hydroxychloroquine Sulphate Plaquenil^®	Tablets 200mg
03.04.01	Hydroxyine Hydrochloride Atarax^®	Tablets 10mg, 25mg
03.04.01	Hydroxyine Hydrochloride Ucerax^®	10mg/5ml syrup Note tablets are blacklisted.
06.04.01.02	Hydroxyprogesterone Unlicensed	Injection 250mg/ml Unlicensed medicine Initiation on the advice of a Consultant in Obs&Gynae
20	HYDROXYPROGESTERONE 250mg/ml inj	For use by Consultants in Obstetrics only
01.02	Hyoscine Butylbromide Buscopan^®	10mg tablets; 20mg/ml injection
17	Hyoscine butylbromide
24.01	Hyoscine butylbromide
03.07	Hypertonic Saline 7% Nebules Nebusal^®	Approved by the HaRD Area Prescribing Committee, January 2015
11.08.01	Hypromellose	Eye drops 0.3%
06.06.02	Ibandronic Acid	50mg tablets. (Note 150mg tablets remain non formulary)
06.06.02	Ibandronic Acid Bonviva^®	Pre-filled syringe 3mg Initiation on the advice of a specialist
08.01.05	Ibrutinib Imbruvica^®	Approved under the Cancer Drugs Fund, February 2015. Available in 90 and 120 capsule pack-sizes
10.01.01	Ibuprofen	Tablets 200mg, 400mg Liquid 100mg/5ml Gel 5% (50g)
24.01	Ibuprofen
24.16	Ibuprofen Neonatal
20.01	Idelalisib 100mg and 150mg tablets Zydelig^®	Approved by the Area Prescribing Committee, November 2014
08.01.01	Ifosfamide Mitoxana^®
13.07	Imiquimod Aldara^®
24.16	Immunisations Neonatal
24.01	Immunoglobulins
24.16	Immunoglobulins Neonatal	To request immunoglobulin, a clinician request form (see link below) needs to be completed before discussion with pharmacy
02.02.01	Indapamide
10.01.01	Indometacin	Capsules 25mg, 50mg MR tablets 75mg
24.01	Infatrini	Paediatric Nutritional products list approved APC 05/18
24.01	Infatrini Peptisorb	Paediatric Nutritional Products List - approved APC 05/18
01.05.03	Infliximab Remicade^®	Consultant request only
10.01.03	Infliximab Remicade^®	Initiation on the advice of a specialist
14.04	Influenza vaccine
13.08.01	Ingenol mebutate gel Picato^®	Approved by HaRD APC April 2013. Not stocked at HDH.
06.01.01.03	Injection devices Clikstar	For glargine and glulisine cartridges
06.01.01.03	Injection Devices HumaPen^® Luxura
06.01.01.03	Injection Devices NovoPen^®
06.01.01.01	Insulin Actrapid^®	Vial For use in the treatment of hyperkalaemia only
06.01.01.01	Insulin Humulin^® S	Cartridge Vial
24.16	Insulin Neonatal	50units in 50ml pre-filled syringe
06.01.01.01	Insulin Aspart NovoRapid^®	Vial Cartridge Flexpen
06.01.01.01	Insulin Aspart Fiasp^®	Vial Cartridge Flexpen Restricted use - Refer to Leeds Amber Guidance as agreed June 2018 APC - see link
24.01	Insulin aspart (Novorapid)
06.01.01.02	Insulin Degludec Tresiba^®
24.01	Insulin degludec (Tresiba)
06.01.02.03	Insulin Degludec 100iu/mL and Liraglutide 3.6mg/mL Xultophy^®	Approved by the Area Prescribing Committee for secondary care use only November 2015.
06.01.01.02	Insulin Detemir Levemir^®	Cartridge Flexpen Long acting insulin analogue of choice for management of type 1 diabetes.
24.01	Insulin detemir (Levemir)
24.01	Insulin glargine (Abasaglar)	Oral - follow BNFc IV - follow prescribing and administration guide
06.01.01.02	Insulin Glargine 100units/ml Lantus	Prescribe by Brand No longer recommended for new patients. Abasaglar is the brand of choice if insulin glargine is required.
06.01.01.02	Insulin Glargine 100units/ml (biosimilar) Abasaglar	Cartridge kwikpen Abasaglar has been shown to be equivalent to Lantus in its pharmacokinetic and pharmacodynamic properties. However, as with other biosimilar medicines, some dose adjustment may be needed for some patients. Biosimilar insulin glargine approved for use in place of Lantus.
06.01.01.01	Insulin Lispro Sanofi or Humalog^®	Vial Cartridge Kwikpen **New patients should be commenced on biosimilar insulin lispro (Sanofi)
24.01	Insulin lispro (Humalog)
09.03	Intralipid 20%	500ml
07.03.04	Intra-uterine Contraceptive Devices Flexi-T^® + 300
07.04.04	Intravesical chondrotin & sodium hyaluronate bladder instillation iAluRil^®	Approved by HaRD Area Prescribing Committee June 2014
06.02.02	Iodine and Iodide Aqueous Iodine Oral Solution	Aqueous solution (Lugol's iodine)
24.01	Ipratropium
03.01.02	Ipratropium Bromide	Inhaler 20mcg/dose Nebules 250mcg/ml, 500mcg/2ml
12.02.02	Ipratropium Bromide Rinatec^®	Nasal spray 0.03%
02.05.05.02	Irbesartan Aprovel ^®	Tablets 75mg 150mg For use by specilaists only for diabetic nephropathy
09.01.01.01	Iron and Folic Acid Pregaday^®	Tablets 100mg iron & 350micrograms folic acid
09.01.01.02	Iron Dextran CosmoFer^®	Injection 50mg/ml Initiation on the advice of a Haematologist Use pre-printed chart
09.01.01.02	Iron Isomaltoside Monofer®	100 mg/ml solution for injection/infusion. Refer to IV Iron Policy
09.01.01.02	Iron Sucrose Venofer	Injection 20mg/ml Use pre-printed chart
15.01.02	Isoflurane
24.16	Isoniazid Neonatal	For treatment of congenital tuberculosis see BNFc
06.01.01.02	Isophane Insulin Pork Hypurin^®	Cartridge
06.01.01.02	Isophane Insulin Insulatard^®	Cartridge Innolet pen
06.01.01.02	Isophane Insulin Humulin^® I	Cartridge Kwikpen
02.07.01	Isoprenaline Sulphate Unlicensed Medicine	Stock kept on ITU only
02.06.01	Isosorbide Dinitrate	Injection 10mg/10ml For use in Cardiac Unit only
02.06.01	Isosorbide Mononitrate	Consider isosorbide mononitrate as monotherapy for stable angina if beta blockers and calcium channel blockers cannot be tolerated or both are contraindicated. Consider adding isosorbide mononitrate if symptoms of stable angina are not controlled with beta blocker or calcium channel blocker monotherapy and the other option (calcium channel blocker or beta blocker) is contraindicated or not tolerated. See NICE CG126: stable angina
13.06.01	Isotretinoin Isotrex Gel^®
13.06.02	Isotretinoin	Capsules
01.06.01	Ispaghula Husk	Sachets 3.5g
02.06.03	Ivabradine Procoralan^®	For use by Cardiologists only. for angina in line with NICE CG126 for heart failure in line with NICE TA267
20.01	Ivermectin 10mg/g cream Soolantra^®	Apply daily and discontinue after 3 months if there is no response. To be used as a third-line treatment option (when Azelaic acid and metronidazole has failed).
13.01	Ixekizumab 80mg solution for injection Taltz^®	Approved by the Area Prescribing Committee, January 2017
15.01.01	Ketamine Ketalar^®
13.09	Ketoconazole Shampoo
06.01.06	Ketones Ketostix^®
01.06.05	Klean-Prep^®
02.04	Labetalol Hydrochloride	Tablets 100mg, 200mg; Injection 100mg/20ml (hospital only)
04.08.01	Lacosamide Vimpat ^®	Tablets 50mg Initiation on the advice of a specialist
01.06.04	Lactulose	For alcohol induced encephalopathy only
24.01	Lactulose
04.08.01	Lamotrigine	Tablets 25mg, 50mg, 100mg, 200mg Dispersible tablets 5mg, 25mg Initiation on the advice of a Neurologist
01.03.05	Lansoprazole	Capsules 15mg 30mg;
01.03.05	Lansoprazole	FasTabs 15mg 30mg for administration down enteral feeding tubes only
24.01	Lansoprazole
09.05.02.02	Lanthanum Fosrenol ^®	Chewable tablets 500mg, 750mg Initiation on the advice of a Renal Specialist
11.06	Latanoprost Xalatan^®	Eye drops 50micrograms/ml
11.06	Latanoprost 0.005% with Timolol 0.5% Xalacom^®	Eye drops (latanoprost 50micrograms/ml & timolol 0.5%)
10.01.03	Leflunomide Arava^®	Tablets 10mg
08.02.04	Lenalidomide Revlimid^®	Patient authorisation form must be sent with each prescription Capsules 10mg, 15mg, 25mg
08.03.04.01	Letrozole Femara^®	Tablets 2.5mg
06.07.02	Leuprorelin Acetate Prostap^®	Injection 3.75mg, 11.25mg Approved in line with Leeds shared care guidelines in March 2014 for the initiation on the advice of a specialist. Not stocked at HDFT
04.08.01	Levetiracetam Keppra^®	Tablets 250mg, 500mg, 1000mg Liquid 500mg/5ml Infusion 500mg/5ml Initiation on the advice of a Neurologist
24.01	Levetiracetam
15.02	Levobupivacaine Chirocaine^®
15.02	Levobupivacaine with Fentanyl
05.01.12	Levofloxacin Tavanic^®
11.03.01	levofloxacin Oftaquix^®	Eye drops 0.5%
17	Levomepromazine	Dose for agitation/distress: 25mg s/c every 3 hours prn Dose for nausea: 6.25mg - 12.5mg s/c every 3 hours prn
07.03.05	Levonogrestrel Levonelle^® 1500	Tablet Levonorgestrel 1.5mg To be used up to 72hours after unprotected sexual intercourse
07.03.02.03	Levonorgestrel 13.5mg intrauterine system Jaydess^®	Approved by HaRD Area Precribing Committee June 2014
07.03.02.03	Levonorgestrel 20mg intrauterine system Mirena^®
06.02.01	Levothyroxine Sodium Levothyroxine	Tablets 25micrograms, 50micrograms, 100micrograms Liquid 25micrograms/5ml
24.16	Lidocaine Neonatal	Infiltration anaesthesia: BNFc
15.02	Lidocaine 2.5% with Prilocaine 2.5% Cream EMLA or Denela^®
15.02	Lidocaine HCl 2% with Chlorhexidine gluconate 0.25% gel Instillagel or Optilube Active^®
15.02	Lidocaine HCl with Adrenaline
02.03.02	Lidocaine Hydrochloride	Infusion 0.1%, 0.2% in glucose 5%
02.03.02	Lidocaine Hydrochloride Minijet^® Lignocaine	100mg/5ml
15.02	Lidocaine Hydrochloride
15.02	Lidocaine hydrochloride LMX 4^®
12.03.01	Lidocaine Hydrochloride 2%, Chlorhexidine Gluconate Solution 0.25% Instillagel^®
15.02	Lidocaine Patch Versatis^®	In exceptional circumstances only - this can be used on a named patient basis by the specialist pain team - December 2017 APC
01.06.07	Linaclotide Constella^®	Approved for one patient only - September 2014
06.01.02.03	Linagliptin Trajenta^®	Tablets 5mg For patients with CKD 3 or 4 (GFR <50ml/min)
05.01.07	Linezolid	For use on microbiology advice ONLY
06.02.01	Liothyronine Sodium	Injection 20micrograms Tablets 20micrograms Not supported for the treatment of hypothyroidism except for the following: • Patients who are allergic to levothyroxine and thus liothyronine is the only treatment option to manage their condition. • Post thyroidectomy thyroid cancer patients. Patients that need to receive radioactive iodine treatment after their surgery will initially be started on liothyronine due to its shorter half-life and therefore faster onset of action. These patients will be switched to levothyroxine when the course of radioactive iodine treatment is completed.
13.02.01	Liquid and White Soft Paraffin Ointment (50:50)	500g
01.06.03	Liquid Paraffin
11.08.01	Liquid Paraffin Xailin Night^®	Eye ointment
06.01.02.03	Liraglutide Victoza^®	Pre-filled pen 18mg/3ml Seek advice from the Specialist Diabetes Team where GLP-1 is being added with insulin in Type-2 diabetes (Amber).
02.05.05.01	Lisinopril	Tablets 2.5mg 5mg 10mg 20mg
04.02.03	Lithium Carbonate Priadel^®	MR tablets 200mg, 400mg Specify brand to avoid confusion between different formulations of lithium
04.02.03	Lithium Citrate Priadel^®	Liquid 520mg/5ml Specify brand to avoid confusion between different formulations of lithium
06.01.02.03	Lixisenatide Lyxumia^®	Approved by HaRD APC April 2013 Seek advice from the Specialist Diabetes Team where GLP-1 is being added with insulin in Type-2 diabetes (Amber).
04.03.01	Lofepramine	Tablets 70mg Liquid 70mg/5ml
04.10	Lofexidine Hydrochloride BritLofex^®	Tablets 200micrograms
08.01.01	Lomustine
01.04.02	Loperamide Hydrochloride	Capsules 2mg; Syrup 1mg/5ml
03.04.01	Loratadine	Formulary in Primary Care (First-line Option) Non-Formulary at HDFT
04.01.02	Lorazepam	Tablets 1mg Injection 4mg/ml
04.08.02	Lorazepam	Injection 4mg/ml An unlicensed preparation is currently in use due to a long-term manufacturing problem with the UK licensed injection. Restricted use
24.01	Lorazepam
02.05.05.02	Losartan Potasium Cozaar^®	Tablets 25mg, 50mg
03.01.05	Low range peak flow meter Mini-Wright^®
01.06.07	Lubiprostone Amitiza^®	Approved by the Area Prescribing Committee September 2014 in line with NICE TA318
20	Lugols Iodine
24.01	Macrogol sachets
01.06.04	Macrogols Movicol^® Paediatric Pain
01.06.04	Macrogols Laxido^®
09.05.01.03	Magnesium Aspartate	Sachets 10mmol
24.01	Magnesium sulfate (acute asthma)
09.05.01.03	Magnesium Sulphate	Injection 50% (2mmol/ml) Infusion 20% (Delivery Suite only)
24.16	Magnesium sulphate Neonatal
13.10.05	Magnesium Sulphate Paste BP
01.01.01	Magnesium Trisilicate Mixture BP
13.10.04	Malathion 0.5% Derbac-M^®
02.02.05	Mannitol	Infusion 10% 20%
20	Measles, Mumps & Rubella Vaccine, Live MMR^®	Approved by the HaRD Area Prescribing Committee, March 2015 for the treatment of viral warts. To be recommended by a Dermatologist only
14.04	Measles, Mumps and Rubella Vaccine, Live (MMR)
01.02	Mebeverine Hydrochloride	Tablets 135mg
13.02.02	Medi-Derma S Barrier Cream
06.04.01.02	Medroxyprogesterone Acetate Sayana Press®	Medicine is licensed for self-administration - patients should be trained to self -administer by the practice nurses. Sharps bin will need prescribing. 104 mg/0.65 ml suspension for injection.
06.04.01.02	Medroxyprogesterone Acetate Provera^® / Depo-Provera	Tablets 5mg, 100mg Depot injection 150mg/ml Initiation on the advice of a specialist
07.03.02.02	Medroxyprogesterone Acetate Depo-Provera^®	Injection 150mg/ml
07.03.02.02	Medroxyprogesterone Acetate Sayana Press®.	Medicine is licensed for self-administration - patients should be trained to self -administer by the practice nurses. Sharps bin will need prescribing. 104 mg/0.65 ml suspension for injection.
08.03.02	Medroxyprogesterone Acetate Provera^®
10.01.01	Mefenamic Acid	Tablets 500mg
08.03.02	Megestrol Acetate Megace^®
04.01.01	Melatonin	Use Circadin tablets - crush and mix with soft food. For initiation by Consultant Paediatrician only
04.01.01	Melatonin Circadin ^®	MR tablets 2mg For initiation by Consultant Neurologists only.
08.01.01	Melphalan Alkeran^®	Tablets 2mg
04.11	Memantine Hydrochloride Ebixa^®
09.06.06	Menadiol Sodium Phosphate	Tablets 10mg (long-term manufacturing problem. Phytomenadione 1mg available)
14.04	Meningococcal group C conjugate vaccine Meningitec^®
24.16	Meningococcal group C conjugate vaccine Neonatal	primary immunisation schedule
14.04	Meningococcal polysaccharide A, C, W135 and Y vaccine ACWY Vax^®
13.03	Menthol 1% in aqueous cream Menthol in aqueous cream	100g and 500g Brands include Arjun and Dermacool
03.08	Menthol and Eucalyptus Inhalation BP 1980
03.04.02	Mepolizumab Nucala^®	Injection 100mg For use by Respiratory consultants only
04.07.02	Meptazinol Meptid^®	Tablets 200mg Injection 100mg/ml For use in obstetric analgesia only
08.01.03	Mercaptopurine Puri-Nethol^®
01.05.03	Mercaptopurine tablets Puri-Nethol^®	Maintenance of remission of acute ulcerative colitis and Crohn’s disease in adults (unlicensed)
05.01.02.02	Meropenem Meronem^®	Injection 1g powder Indicated for: Neutropenic Sepsis in patients with a non-severe penicillin allergy. Microbiology advice should be sought for all other indications.
24.01	Meropenem	On the advice of Microbiology
24.16	Meropenem Neonatal
01.05.01	Mesalazine Octasa^®	Tablets 400mg, 800mg - Asacol brand (for doses over 2.4g daily only); Foam enema 1g; Suppositories 500mg
01.05.01	Mesalazine Pentasa^®	MR tablets 500mg; Retention enema 1g/100ml; Suppositories 1g
01.05.01	Mesalazine Mezavant^® XL	MR tablets 1.2g For use by Consultant Gastroenterologists only, for patients non-compliant with other oral mesalazine preparations.
08.01	Mesna Uromitxan^®
24.01	Metabolic formulary
24.16	Metanium Neonatal
06.01.02.02	Metformin Hydrochloride Metformin^®	Tablets 500mg, 850mg Sachets 500mg
06.01.02.02	Metformin Hydrochloride Glucophage^® SR	MR tablets 500mg, 750mg Initiation on the advice of a specialist
04.10	Methadone Hydrochloride	Mixture 1mg/ml Initiation on the advice of a Consultant Psychiatrist
05.01.13	Methenamine Hippurate Hiprex^®	On the advice of Microbiology
08.01.03	Methotrexate	Tablets 2.5mg Injection 10mg, 12.5mg, 15mg, 17.5mg, 20mg, 22.5mg, 25mg, 30mg, 50mg, 75mg
10.01.03	Methotrexate Rheumatology	Tablets 2.5mg Injection (various strengths available in pre-filled syringes)
13.05.03	Methotrexate
13.08.01	Methyl-5-Aminolevulinate Metvix^®
01.06.06	Methylnaltrexone Relistor^®	Injection 12mg For Palliative Care Consultants only
24.01	Methylphenidate
04.04	Methylphenidate Hydrochloride Medikinet	Tablets 10mg Initiation on the advice of a specialist
10.01.02.02	Methylprednisolone Acetate Depo-Medrone^®	Injection 40mg/ml, 80mg/2ml, 120mg/3ml
10.01.02.02	Methylprednisolone Acetate Depo-Medrone^® with Lidocaine	Injection Methylprednisolone 40mg /lidocaine 10mg/ml
01.02	Metoclopramide	Tablets 10mg; Syrup 5mg/5ml See section 4.6
17	Metoclopramide	Dose: 10mg - 20mg s/c every 6 hours prn
24.01	Metoclopramide
04.06	Metoclopramide Hydrochloride	Tablets 10mg Liquid 5mg/5ml Injection 10mg/2ml
02.02.01	Metolazone Unlicensed
02.04	Metoprolol Tartrate	Tablets 50mg
05.01.11	Metronidazole	Tablets 200mg, 400mg Liquid 200mg/5ml Suppositories 500mg, 1g
24.01	Metronidazole	Oral - follow BNFc IV - follow prescribing and administration guide
24.16	Metronidazole Neonatal
13.10.01.02	Metronidazole 0.75% Gel	Brands include Anabact and Metrosa
12.03.02	Miconazole Daktarin^®	Oral gel 20mg/g
13.10.02	Miconazole Nitrate
24.16	Miconazole oral gel / topical cream (Daktarin^®) Neonatal
04.08.02	Midazolam Buccolam^®	Buccal liquid - Pre-filled syringes (4) 2.5mg, 5mg, 7.5mg, 10mg 3 to 6 months(Hospital setting) 2.5mg in 0.5ml (Yellow) >6 months to <1 year 2.5mg in 0.5ml (Yellow) 1 year to <5 years 5mg in 1ml (Blue) 5 years to <10 years 7.5mg in 1.5ml (Purple) 10 years to <18 years 10mg in 2ml (Orange)
15.01.04.01	Midazolam
17	Midazolam	Dose: 2.5mg - 5mg s/c every 1 hour prn.
24.16	Midazolam Neonatal
24.01	Midazolam buccal (Buccolam)
24.01	Midazolam injection
02.07	Midodrine Unlicensed	Tablets 5mg For use by specialists only
20	MIDODRINE Tablets 2.5 mg, 5mg	For use in postural hypotension if licensed options have failed e.g. fludrocortisone
07.01.02	Mifepristone Mifegyne^®	Tablets 200mg
07.04.02	Mirabegron Betmiga^®	Approved by HaRD APC July 2013
04.03.04	Mirtazapine	Tablets 15mg, 30mg
08.01.02	Mitomycin Mitomycin C Kyowa^®
20	Mitomycin-C	0.2mg/1ml 0.4mg/1ml Approved by HaRD Area Prescribing Committee June 2014 For Consultant Ophthalmolgist use only
08.01.02	Mitoxantrone (Mitozantrone)
15.01.05	Mivacurium Chloride Mivacron^®
04.04	Modafinil Provigil^®	Tablets 100mg Initiation on the advice of a specialist
12.02.01	Mometasone Furoate Nasonex^®	Nasal spray 50micrograms/metered spray
13.04	Mometasone Furoate 0.1% Elocon^®	Cream 30g, 100g Ointment 30g, 100g
03.03.02	Montelukast Singulair^®	Tablets 10mg Chewable tablets 4mg, 5mg Granules 4mg For initiation by respiratory specialists only
24.01	Montelukast
24.01	Morphine
03.09.01	Morphine Hydrochloride
04.07.02	Morphine Sulphate	MR tablets 10mg, 30mg, 60mg, 100mg (Zomorph preferred choice in primary care) Liquid 10mg/5ml, 100mg/5ml Injection 10mg/ml, 15mg/ml Syringe for PCA 50mg/50ml Oral solution 100micrograms/ml(for use in SCBU)
24.16	Morphine sulphate Neonatal
20	Morphine sulphate 100mg/100ml
09.05.03	Mouthwash tablets Tellodont^®	Soluble tablets
12.03.04	Mouthwash tablets
11.03.01	Moxifloxacin 0.1mg/0.1ml (unlicensed)	Intracameral injection. Antibacterial prophylaxis in cataract surgery where cefuroxime is contra-indicated. Approved by HaRD Area Prescribing Committee Feb 2014
02.05.02	Moxonidine	Tablets 200micrograms For use by a specialist only
13.10.01.01	Mupirocin Bactroban^®
12.02.03	Mupirocin 2% in White Soft Paraffin Bactroban Nasal^®	Nasal ointment 2%
09.06.07	Mutivitamin	Tablets
08.02.01	Mycophenolate Mofetil	Prescribe generically
02.06.04	Naftidrofuryl Oxalate	Formulary as per NICE TA223
04.10.01	Nalmefene Selincro	To be prescribed by the community alcohol service provided by North Yorkshire Horizons only.
01.06	Naloxegol oxalate Moventig^®	12.5mg and 25mg tablets Approved in line with NICE TA345
24.16	Naloxone Neonatal
15.01.07	Naloxone Hydrochloride Naloxone^®
10.01.01	Naproxen	Tablets 250mg Switched to HDFT NSAID of choice November 2012 due to increased CV risk with diclofenac
06.01.02.03	Nateglinide Starlix^®	Tablets 120mg Initiation on the advice of a specialist
02.04	Nebivolol Nebilet^®	Cardiology initiation only
11.04.02	Neodocromil Sodium Rapitil^®	Eye drops 2%
10.02.01	Neostigmine	Injection 2.5mg/ml
15.01.06	Neostigmine Metilsulfate
15.01.06	Neostigmine Metilsulfate with Glycopyrronium Robinul-Neostigmine^®
02.06.03	Nicorandil Ikorel^®
04.10	Nicotine Niquitin CQ^® patches	Patches, 7mg, 14mg and 21mg strength
02.06.02	Nifedipine Adalat^® Retard	MR tablets 10mg, 20mg (twice daily dosing) Prescribe by brand
02.06.02	Nifedipine	Capsules 5mg, 10mg
02.06.02	Nifedipine Adalat^® LA	MR tablets 20mg, 30mg, 60mg (once daily dosing) Prescribe by brand
02.06.02	Nifedipine Coracten^® SR	MR capsules 10mg (twice daily dosing) Prescribe by brand
08.01.05	Nilotinib Tasigna^®
04.01.01	Nitrazepam	Tablets 5mg Liquid 2.5mg/ml
05.01.13	Nitrofurantoin	Tablets 100mg Capsules 50mg Liquid 25mg/5ml MR capsules 100mg
24.01	Nitrofurantoin
15.01.02	Nitrous oxide
24.01	Nitrous Oxide (Entonox)
24.01	Noradrenaline
24.16	Noradrenaline Neonatal
02.07.02	Noradrenaline Acid Tartrate / Norepinephrine Bitartrate Noradrenaline ^®/ Norepinephrine	Injection 2mg/ml (equivalent to noradrenaline base 1mg/ml)
06.04.01.02	Norethisterone	Tablets 5mg Initiation on the advice of a specialist
08.03.02	Norethisterone
14.05.01	Normal Immunoglobulin for Intravenous use Privigen^®	There is a National Immunoglobulin Database which must be updated for every patient commenced on immunoglublin therapy. Sections 1-3 of the attached immunoglobulin request form must be completed by the requesting clinician and sent to Pharmacy Aseptics.
24.01	Nutrini	Paediatric Nutritional Products List - approved APC 05/18
24.01	Nutrini Energy	Paediatric Nutritional Products List - approved APC 05/18
24.01	Nutrini Energy Mulifibre	Paediatric Nutritional Products List - approved APC 05/18
24.01	Nutrini Multifibre	Paediatric Nutritional Products List - approved APC 05/18
24.01	Nutrini Peptisorb	Paediatric Nutritional Products List - approved APC 05/18
24.01	Nutrini Peptisorb Energy	Paediatric Nutritional Products List - approved APC 05/18
24.16	Nutriprem 2 Neonatal
16.01	Nutrison Multifibre	Refeeding protocol approved APC July 2018 - see link
12.03.02	Nystatin Nystan^®	Oral solution 100 000units/ml
24.16	Nystatin Neonatal	Oral liquid Topical cream discontinued
01.09.01	Obeticholic acid Ocaliva^®
11.08.02	Ocriplasmin 0.5 mg/0.2 ml concentrate for solution for injection Jetrea	Administered by intravitreal injection only
24.16	Octenisan Neonatal	Use daily as a wash from 28 weeks of age
08.03.04.03	Octreotide Sandosatin^®	Injection 50micrograms/ml, 100micrograms/ml Initiation on teh advice of a specialist
08.03.04.03	Octreotide Sandosatin Lar^®	Injection 10mg Initiation on the advice of a specialist
06.04.01.01	Oestrogens for HRT Premarin^®	Tablets 625micrograms Initiation on the advice of a specialist
06.04.01.01	Oestrogens for HRT Climaval^®	Approved by the Area Prescribing Committee, February 2015 1mg and 2mg tablets available.
06.04.01.01	Oestrogens for HRT Evorel^®	Patch 50micrograms/24 hours If patient experiences skin irritation from the patches, refer to GP for matrix patches
06.04.01.01	Oestrogens for HRT Premique^®	All oestrogen and HRT products should only be prescribed on the advice of a specialist. Always consider lowest dose possible - refer new patients to GP for Premique low dose.
06.04.01.01	Oestrogens for HRT Prempak-C^®	Tablets 1.25 Initiation on the advice of a specialist
07.02.01	Oestrogens, Topical Gynest^®	Intravaginal cream 0.01%
07.02.01	Oestrogens, Topical Ortho-Gynest^®	Pessaries 500micrograms
07.02.01	Oestrogens, Topical Ovestin^®	Intravaginal estriol cream 0.1%
08.02.03	Ofatumumab Arzerra^®	Approved by the HaRD Area Prescribing Committee, March 2015
11.03.01	Ofloxacin Exocin^®	Eye drops 0.3%
04.02.01	Olanzapine Zyprexa^®	Tablets 2.5mg, 5mg, 10mg Orodispersible tablets 5mg, 10mg
12.01.03	Olive Oil
03.04.02	Omalizumab Xolair^®	Injection 150mg For use by respiratory consultants only
01.03.05	Omeprazole	Capsules 10mg 20mg
24.01	Omeprazole	Omeprazole liquid preparations are not routinely used at HDFT - use omeprazole dispersible tablets
24.16	Omeprazole Neonatal
01.03.05	Omeprazole IV
04.06	Ondansetron	Tablets 4mg, 8mg Liquid 4mg/5ml Injection 4mg/2ml, 8mg/4ml
24.01	Ondansetron
04.09.01	Opicapone Ongentys^®	Approved by the Area Prescribing Committee, January 2017 Second line treatment option for patients unable to tolerate entacapone or where it is contraindicated.
07.03.02	Oral Progestogen-Only Contraceptives Morningside^®	Tablets Desogestrel 75micrograms
07.03.02	Oral Progestogen-Only Contraceptives Micronor^®	Tablets Norethisterone 350micrograms
07.03.02	Oral Progestogen-Only Contraceptives Norgeston^®	Tablets Levonorgestrel 30micrograms
24.01	Oral rehydration sachets
09.02.01.02	Oral Rehydration Salts	Plain/Blackcurrant flavour
04.05.01	Orlistat Xenical^®	Capsules 120mg Initiation on the advice of a specialist
05.03.04	Oseltamivir Tamiflu^®	On the advice of a Microbiologist
08.01.05	Oxaliplatin
04.01.02	Oxazepam	Tablets 10mg, 15mg For alcohol detoxification if impaired liver function
11.07	Oxybuprocaine Hydrochloride Minims^®	Eye drops 0.4%
07.04.02	Oxybutynin Hydrochloride	Tablets 2.5mg, 5mg Liquid 2.5mg/5ml
17	Oxycodone	Opiate of choice in moderate renal function
04.07.02	Oxycodone Hydrochloride OxyContin^®	MR tablets 5mg, 10mg, 40mg, 80mg For regular TWICE DAILY dosing Morphine is first line strong opioid of choice
04.07.02	Oxycodone Hydrochloride OxyNorm^®	Standard release capsules 5mg, 10mg (PRN for breakthrough pain) Liquid 5mg/5ml (250ml bottles) Liquid 50mg/5ml (120ml bottles) Injection 10mg/ml, 20mg/2ml, 50mg/ml
05.01.03	Oxytetracycline	Tablets 250mg
07.01.01	Oxytocin Syntocinon^®	Injection 5units/ml, 10units/ml
08.01.05	Paclitaxel
04.02.02	Paliperidone Xeplion	50mg, 75mg, 100mg, 150mg prefilled syringe
24.16	Palivizumab Neonatal	Restricted to use for RSV prophylaxis in patients who meet the Yorkshire and Humber Specialised Commissioning Group criteria
04.06	Palonosetron with netupitant Akynzeo^®	Approved by HaRD APC April 2017
01.09.04	Pancreatin Creon^® 40000
01.09.04	Pancreatin Creon^® 25000
01.09.04	Pancreatin Creon^® 10000
24.16	Pancuronium Neonatal
15.01.05	Pancuronium Bromide
14.04	Pandemic Influenza A(H1N1)v vaccine Celvapan^®
08.01.05	Panitumumab ^®
04.07.01	Paracetamol	Tablets 500mg, Soluble tablets 500mg Suppositories 60mg, 120mg, 250mg, 500mg Liquid 120mg/5ml, 250mg/5ml Intravenous infusion 10mg/ml* * Restricted
04.08.03	Paracetamol	For formulations see under Analgesics
24.01	Paracetamol
24.16	Paracetamol Neonatal
04.07.01	Paracetamol and codeine Co-codamol^® 8/500	Tablets Soluble tablets
04.07.01	Paracetamol and codeine Co-codamol^® 30/500	Tablets
04.07.01	Paracetamol and dihydrocodeine Co-dydramol^®	Tablets 10/500
20	PARAFFIN WHITE SOFT BP 350g
24.01	Paraldehyde & oilve oil enema	Unlicensed
20	PARALDEHYDE 50% in olive oil enema 30ml
15.01.04.02	Parecoxib Dynastat^®
07.03.02.02	Parenteral Progestogen Only Contraceptives Nexplanon^®	Implant Etonorgestrel 68mg
04.03.03	Paroxetine	Tablets 20mg, 30mg Liquid 10mg/5ml
20	PATENT BLUE Injection 2.5%
09.01.06	Pegfilgrastim Neulasta^®	Pre-filled syringe 6mg/0.6ml Initiation by Consultant Haematologist/Oncologist only
08.01.05	Pembrolizumab Keytruda^®
08.01.03	Pemetrexed Alimta^®
20	PENTOSAN POLYSULPHATE 100mg capsules Elmiron^®	Request through HaRD APC on an individual named patient basis Licensed drug now available - pending request to HaRC APC
02.06.04	Pentoxifylline Trental^®
01.02	Peppermint Oil Mintec^®	Capsules e/c 0.2ml
01.02	Peppermint water
20	PEPPERMINT WATER BP
01.01.02	Peptac
04.08.01	Perampanel Fycompa^®	Initiation on the advice of a Specialist
02.05.05.01	Perindopril erbutine	Tablets 2mg 4mg For use by specialists in stroke patients only Perindopril Erbutine only
13.10.04	Permethrin
04.07.02	Pethidine Hydrochloride	Injection 50micrograms/ml, 100micrograms/2ml
04.08.01	Phenobarbital	Tablets 30mg Liquid 50mg/5ml (alcohol free) Injection 30mg/ml, 200mg/ml
24.01	Phenobarbital (Phenobarbitone)
24.16	Phenobarbital (Phenobarbitone) Neonatal
05.01.01.01	Phenoxymethylpenicillin	Tablets 250mg Syrup 125mg/5ml & 250mg/5ml
24.01	Phenoxymethylpenicillin
24.16	Phenylephrine 2.5% minims Neonatal
11.05	Phenylephrine Hydrochloride Minims^® Phenylephrine Hydrochloride	Eye drops 2.5%, 10%
04.08.01	Phenytoin	Phenytoin sodium Tablets 100mg, Chewable tablets 50mg Capsules 25mg, 50mg, 100mg Injection 250mg/5ml Phenytoin Liquid 30mg/5ml (Phenytoin sodium 100mg = Phenytoin 90mg)
24.01	Phenytoin
24.16	Phenytoin Neonatal
03.09.01	Pholcodine Linctus, BP	Liquid 5mg/5ml
09.02	Phosphate Infusion Polyfuser	See link to hypophosphataemia guidelines
09.05.02.01	Phosphate supplements	Effervescent tablets (Phosphate Sandoz): Phosphate 16.1mmol, Potassium 3.1mmol, Sodium 20.4mmol per tablet Polyfusor (500ml): Phosphate 50mmol, Potassium 9.5mmol, Sodium 81mmol in 500ml
01.06.04	Phosphates (Rectal) Fleet^® Ready to use Enema
09.06.06	Phytomenadione Konakion^® MM	Injection 10mg/ml
09.06.06	Phytomenadione Konakion^® MM Paediatric	Injection (can be used orally) 2mg/0.2ml
11.06	Pilocarpine	Eye drops 1%, 2%, 4% Minims 4%
13.05.03	Pimecrolimus Elidel^®
06.01.02.03	Pioglitazone Actos^®	Tablets 30mg Initiation on the advice of a specialist
05.01.01.04	Piperacillin and Tazobactam	Injection 4.5g powder Should be prescribed as 'piperacillin/tazobactam' to identify it as a penicillin. Approved Indications: Hospital Acquired Pneumonia (HAP) Ventilator Associated Pneumonia (VAP) Aspiration Pneumonia Neutropenic Sepsis Microbiology advice should be sought for all other indications
03.11	Pirfenidone
05.01.01.05	Pivmecillinam Selexid^®	Tablets 200mg
04.07.04.02	Pizotifen	Tablets 500micrograms
14.04	Pneumococcal polysaccharide conjugate vaccine (13-valent adsorbed) Prevenar 13^®
14.04	Pneumococcal polysaccharide vaccine Pneumovax^® II
24.16	Pneumococcal vaccine (Prevenar13) Neonatal
13.07	Podophyllotoxin Warticon^®
06.01.06	Polycal
09.02.01.01	Polystyrene Sukphonate Resins Calcium Resonium^®	Oral powder
11.08.01	Polyvinyl Alchohol SnoTears^®	Eye drops 1.4%
11.08.01	Polyvinyl Alcohol Liquifilm Tears^®	Single dose eye drops 1.4%
08.02.04	Pomalidomide Imnovid^®
24.16	Poractant alfa (Curosurf) Neonatal
09.02.01.01	Potasium Chloride Sando-K^®	Effervescent tablets (12mmol potassium)
09.02.01.01	Potasium Chloride Slow-K^®	MR tablets 600mg (8mmol potassium) MR tablets only to be prescribed if effervescent tablets or liquid preparations are inappropriate. Branded proect has been discontinued only specialsare available to order - these may be expensive.
09.02.01.01	Potasium Chloride Kay-Cee-L^®	Liquid 1mmol/ml potassium
09.02.02.01	Potassium Chloride and Glucose Intravenous Infusion	Potassium 0.15%(20mmol), Glucose 5% (1000ml) Potassium 0.3%(40mmol), Glucose 5% (1000ml) Potassium 0.3%(40mmol), Glucose 10% (500ml)
09.02.02.01	Potassium Chloride and Sodium Chloride Intravenous Infusion	Potassium 0.15%(20mmol), NaCl 0.9% (1000ml) Potassium 0.3%(40mmol), NaCl 0.9% (1000ml) Potassium 0.45%(60mmol), NaCl 0.9% (1000ml) Potassium 0.6%(80mmol), NaCl 0.9% (500ml) *ECG monitoring required
09.02.02.01	Potassium Chloride Concentrate (Sterile)	Pre-filled syringe 50mmol/50ml For use on ITU only
09.02.02.01	Potassium Chloride, Sodium Chloride and Glucose Intravenous Infusion	Potassium 0.15%(20mmol),NaCl 0.45%,Glucose 5% (500ml) Potassium 0.3%(40mmol),NaCl 0.18%,Glucose 4% (1000ml) Potassium 0.3%(40mmol),NaCl 0.45%,Glucose 5% (500ml) Potassium 0.15%(20mmol),NaCl 0.18%,Glucose 4% (500ml) SCBU only
07.04.03	Potassium Citrate	Mixture 200ml
13.11.06	Potassium Permanganate Permitabs^®
13.11.04	Povidone-Iodine Videne^®
04.09.01	Pramipexole	Tablets 180micogram base (= 250micogram salt), 700micogram base (= 1000microgram salt) Initiation on the advice of a specialist MR formulation: Individual patient request required through LPG. Preferred product of choice in primary care is Pipexus MR
02.09	Prasugrel Efient^®	Tablets 5mg, 10mg For use by a specialist only
02.12	Pravastatin Sodium	Tablets 10mg, 20mg Use if adverse effects with simvastatin
01.05.02	Prednisolone Predfoam^®	Foam enema 20mg
01.05.02	Prednisolone Predsol	Retention enema 20mg/100ml
01.05.02	Prednisolone Predsol	Retention enema 20mg/100ml; Suppositories 5mg
06.03.02	Prednisolone	Tablets 1mg, 5mg
11.04.01	Prednisolone	Eye drops 0.5% Eye drops 1% (Predforte)
11.04.01	Prednisolone Minims^® Prednisolone Sodium Phosphate	Eye drops 0.5%
24.01	Prednisolone
04.07.03	Pregabalin	Also approved as an unlicensed indication pre-operatively as part of the gynae enhanced recovery protocol.
04.08.01	Pregabalin
15.02	Prilocaine 2% injection Prilotekal^®	Approved by HaRD Area Prescribing Committee September 2013: For subarachnoid block in adult day surgery cases where procedures last under 1 hour
15.02	Prilocaine Hydrochloride Citanest^®
15.02	Prilocaine Hydrochloride with Felypressin Citanest with Octapressin^®
03.05.02	Proactant Alfa Curosurf^®	Injection 120mg, 240mg For use on Special Care Baby Unit only
20.01	Probiotics VSL #3 Sachets and other brands	•Only approved for adults (pouchitis) •All other indications: BLACK - Not recommended for prescribing within the Harrogate and Rural District CCG.
04.06	Prochlorperazine	Tablets 5mg Liquid 5mg/5ml Injection 12.5mg/ml
04.06	Prochlorperazine Buccastem^® (Buccal preparation)
04.09.02	Procyclidine Hydrochloride	Tablets 5mg Liquid 5mg/5ml Injection 10mg/2ml
04.06	Promethazine Hydrochloride	Tablets 25mg Liquid 5mg/5ml Injection 25mg/ml
13.12	Propantheline Pro-Banthine ^®
15.01.01	Propofol
24.01	Propranolol
24.01	Propranolol (haemangioma)	Unlicensed indication
02.04	Propranolol Hydrochloride Inderal^® LA	MR Capsules 160mg
02.04	Propranolol Hydrochloride Half-Inderal^® LA	MR Capsules 80mg
02.04	Propranolol Hydrochloride
06.02.02	Propylthiouracil
16.01	ProSource Plus	Approved by the HaRD Area Prescribing Committee, March 2015
02.08.03	Protamine Sulphate	Injection 10mg/ml
24.16	Proxymetacaine 0.5% eye drops Neonatal
11.07	Proxymetacaine Hydrochloride 0.5% with Fluorescein Sodium 0.25% Minims^®
01.06.07	Prucalopride Resolor	Tablets 1mg Initiation on the advice of a specialist only. For chronic constipation in adults when all other laxatives have been ineffective after 6 months.
03.10	Psudoephedrine Hydrochloride Gulpseud^®
03.10	Psudoephedrine Hydrochloride Sudafed^®	Tablets 60mg Liquid 30mg/5ml
05.01.09	Pyrazinamide
10.02.01	Pyridostigmine Bromide Mestinon^®	Tablets 60mg
09.06.02	Pyridoxine Hydrochloride Pyridoxine	Tablets 50mg
04.02.01	Quetiapine Seroquel^®	Tablets 25mg, 100mg, 200mg, 300mg
06.07.01	Quinagolide Norprolac^®	Tablets 25 & 50micrograms (in starter pack), Tablets 75micrograms Initiation on the advice of a specialist
10.02.02	Quinine sulphate	Tablets 200mg
06.04.01.01	Raloxifene Hydrochloride Evisa^®
02.05.05.01	Ramipril	Capsules 2.5mg 5mg 10mg
11.08.02	Ranibizumab Lucentis^®	Intravitreal injection 10mg/ml Initiation by Consultant Ophthalmologist only
01.03.01	Ranitidine	Tablets 150mg, 300mg; Liquid 75mg/5ml
24.01	Ranitidine	APC April 2018 -Effervescent ranitidine tablets should be used in patients under 6 years old instead of liquid due to the alcohol content of the liquid being contraindicated for this group.
24.16	Ranitidine Neonatal	APC April 2018- Effervescent ranitidine tablets should be used in patients under 6 years old instead of liquid due to the alcohol content of the liquid being contraindicated for this group.
01.03.01	Ranitidine IV	Injection 50mg/2ml
02.06.03	Ranolazine Ranexa^®	Consider ranolazine as monotherapy for stable angina if beta blockers and calcium channel blockers cannot be tolerated or both are contraindicated. Consider adding ranolazine if symptoms of stable angina are not controlled with beta blocker or calcium channel blocker monotherapy and the other option (calcium channel blocker or beta blocker) is contraindicated or not tolerated. See NICE CG126: stable angina
04.09.01	Rasagiline Azilect^®	Tablets 1mg Initiation on the advice of a specialist
04.03.04	Reboxetine Edronex^®	Tablets 4mg
15.01.04.03	Remifentanil Ultiva^®
03.04.02	Reslizumab Cinqaero	For use by Respiratory Consultants Only For severe eosinophilic asthma
04.08.01	Retigabine Trobolt^®	Tablets 50mg, 100mg Initiation on the advice of a specialist only. Used as add on treatment in patients with focal onset seizures, which have not been controlled with all other licensed anti-epileptic drug. Comprehensive eye examination required prior to initiation and then repeated every 6 months.
05.01.09	Rifampicin	Capsules 150mg, 300mg Liquid 100mg/5ml Infusion 600mg
05.01.09	Rifampicin and Isoniazid Rifinah^® 150 and 300
05.01.09	Rifampicin and Isoniazid and Pyrazinamide Rifater^®
05.01.07	Rifaximin 550mg tablets Targaxan^®	Approved by the Area Prescribing Committee, May 2015, in line with NICE TA337
04.09.03	Riluzole Rilutek^®	Tablets 50mg Initiation on the advice of a specialist
11.04.01	Rimexolone Vexol^®	Eye drops 1%
04.05.02	Rimonabant Acomplia^®	Not stocked at HDFT Initiation on the advice of a specialist
06.06.02	Risedronate Sodium Actonel^®	Tablets 35mg Tablets 30mg (for Pagets disease only)
04.02.01	Risperidone Risperdal^®	Tablets 500 micrograms, 1mg, 3mg Liquid 1mg/ml
04.02.02	Risperidone Risperdal Consta^®	Injection 25mg, 37.5mg, 50mg
07.01.03	Ritodrine Hydrochloride Yutopar^®	Tablets 10mg
08.02.03	Rituximab Truxima^®
10.01.03	Rituximab Truxima^®	Initiation on the advice of a specialist
02.08.02	Rivaroxaban Xarelto^®	As per NICE guidelines
04.11	Rivastigmine	Capsules 1.5mg Patches 4.6mg Initiation on the advice of a specialist. Patches ONLY for patients unable to take capsules.
20	ROBINUL-NEOSTIGMINE inj (1ml)
15.01.05	Rocuronium Bromide Esmeron^®
03.03.03	Roflumilast Daxas	500mcg tablets Not currently prescribed at HDH
04.09.01	Ropinirole	Tablets 250micrograms, 1mg Initiation on the advice of a specialist
04.09.01	Ropinirole MR (XL) Ipnnia XL^®	2mg, 3mg, 4mg, 6mg and 8mg tablets
02.12	Rosuvastatin Crestor^®	Tablets 5mg, 10mg, 20mg For use by Consultant Cardiologists only
14.04	Rotavirus vaccine Rotarix^®
24.16	Rotavirus vaccine (Rotarix) Neonatal
04.09.01	Rotigotine Neupro^®	Patches 2mg, 4mg, 6mg, 8mg Initiation on the advice of a specialist
02.05.05.02	Sacubitril/valsartan Entresto^®	To be prescribed in line with NICE TA388
04.09.01	Safinamide Xadago^®	50mg and 100mg film coated tablets Approved by the HaRD Area Prescribing Committee December 2016
03.01.01.01	Salbutamol	Inhaler 100micrograms/dose Easyhaler 100micrograms/dose Nebules 2.5mg/2.5ml, 5mg/2.5ml MR tablets 4mg Liquid 2mg/5ml Injection 500micrograms/ml (hospital only)
07.01.03	Salbutamol	Nebules 5mg
24.01	Salbutamol
24.16	Salbutamol Neonatal	For the management of hyperkalaemia. If IV route is unavailable, follow guidance in BNFc.
13.07	Salicylic Acid Occlusal^®
13.05.02	Salicylic Acid 2% w/w, Sulphur 2% w/w in Aqueous Cream
13.06.01	Salicylic Acid 3% w/w, Sulphur 3% w/w in Aqueous Cream
13.05.02	Salicylic Acid in White Soft Paraffin
13.06.01	Salicylic Acid in White Soft Paraffin
03.01.01.01	Salmeterol Serevent^®
10.01.03	Sarilumab
01.07.02	Scheriproct	Ointment
20.01	Secukinumab Cosentyx^®	Approved in line with NICE TA350
04.09.01	Selegiline Hydrochloride	Tablets 5mg Liquid 10mg/5ml
06.01.02.03	Semaglutide pre filled pen Ozempic	0.25mg, 0.5mg, 1mg
01.06.02	Senna	Tablets 7.5mg; Liquid 7.5mg/5ml
04.03.03	Sertraline	Tablets 50mg, 100mg
09.05.02.02	Sevelamer Renagel^®	Tablets 800mg Initiation on the advice of a Renal Specialist
15.01.02	Sevoflurane
13.09	Shampoos Capasal^®
04.05.02	Sibutramine Hydrochloride Reductil^®	Capsules 10mg Initiation on the advice of a specialist
07.04.05	Sildenafil Viagra^®
13.07	Silver Nitrate
13.10.01.01	Silver Sulfadiazine Flamazine^®
24.01	Similac Alimentum	Paediatric Nutritional Products List - approved APC 05/18
03.09.02	Simple Linctus, BP
02.12	Simvastatin	Tablets 20mg, 40mg
08.02.02	Sirolimus Rapamune^®
06.01.02.03	Sitagliptin Januvia^®	Tablets 100mg Initiation on the advice of a specialist
24.01	Sodium benzoate	Unlicensed
09.02.01.03	Sodium Bicarbonate	Capsules 500mg
09.02.02.01	Sodium Bicarbonate Min-I-Jet^® Sodium Bicarbonate	Minijet 4.2%, 8.4%
12.01.03	Sodium Bicarbonate	Ear drops 5%
24.16	Sodium bicarbonate Neonatal
09.02.02.01	Sodium Bicarbonate Infusion	Polyfusor 1.26% (500ml) 2.74% (500ml) 4.2% (500ml) 8.4% (200ml)
03.01.05	Sodium Chloride	Sodium chloride 0.9% 5ml, 10ml
24.16	Sodium chloride Neonatal	Oral product used at HDFT is sodium chloride 1mmol/1mL 200mL (unlicensed medicine)
13.11.01	Sodium Chloride 0.9%
09.02.02.01	Sodium chloride 3% solution Hypertonic saline
09.02.02.01	Sodium Chloride and Glucose Intravenous Infusion	NaCl 0.9%, Glucose 5% (500ml) NaCl 0.45%, Glucose 5% (500ml) NaCl 0.18%, Glucose 4% (500ml) NaCl 0.18%, Glucose 4% (1000ml) NaCl 0.18%, Glucose 10% (500ml)
09.02.02.01	Sodium Chloride Intravenous	0.45% (500ml) 0.9% (50ml & 50ml Minibag plus) 0.9% (100ml & 100ml Minibag plus) 0.9% (250ml) 0.9% (500ml) 0.9% (1000ml) 5% Polyfusor (500ml)
07.04.04	Sodium Citrate	Solution for bladder irrigation 30ml
01.06.04	Sodium Citrate (Rectal) Micralax^® Micr-enema
11.04.02	Sodium Cromoglicate	Eye drops 2%
09.01.01.01	Sodium Feredetate Sytron^®	Liquid 27.5mg iron in 5ml
05.01.07	Sodium fusidate	Tablets 250mg Liquid 250mg/5ml (Dose of 750mg TDS equivalent to 500mg TDS for tablets) Infusion 500mg powder with diluent
11.08.01	Sodium hyaluronate 0.2% Xailin HA^®	Approved by the Area Prescribing Committee, August 2016
13.11.04	Sodium Hypochorite Solution 1% Milton^®
09.02.02.01	Sodium Lactate Intravenous Infusion, Compound	500ml, 1000ml
24.16	Sodium Phosphate Neonatal	Joulies phosphate solution (unlicensed medicine)
01.06.02	Sodium Picosulfate	Elixir 5mg/5ml
24.01	Sodium picosulfate
04.08.01	Sodium Valproate	Crushable tablets 100mg EC tablets 200mg, 500mg MR tablets 300mg, 500mg Liquid 200mg/5ml Injection 300mg/3ml
24.01	Sodium valproate
07.04.02	Solifenacin Succinate Vesicare^®	Tablets 5mg, 10mg
02.04	Sotalol Hydrochloride	Tablets 40mg, 80mg
02.02.03	Spironolactone
24.16	Spironolactone Neonatal
03.01.05	Standard range peak flow meter MicroPeak^®
13.11.07	Sterile Larvae (Maggots) LarvE^®
12.03.03	Strepsils lozenges	Original
02.10.02	Streptokinase	Injection 1.5million units Intrapleural use for empyema
01.03.03	Sucralfate Antepsin^®	Unlicensed preparation approved for use by the gastroenterology consultants only. Approved as a Red Drug until the licensed preparation is available again.
20	Sucralfate 2g/50ml enema	Management of chronic radiation proctitis.
20	Sucrose 24% Sweet-Ease^®	For procedural pain relief in neonates
01.05.01	Sulfasalazine	Tablets plain/ e/c 500mg (note plain tablets are cheaper than e/c in primary care)
10.01.03	Sulfasalazine	Tablets EC 500mg
04.02.01	Sulpiride	Tablets 200mg; Liquid 200mg/5ml
04.07.04.01	Sumatriptan	Tablets 50mg
24.01	Sumatriptan
24.16	Suxamethonium Neonatal
15.01.05	Suxamethonium Chloride
24.16	Syrup BP Neonatal	Unlicensed For cannulation
24.16	Sytron (Sodium feredetate) Neonatal	For all breast milk fed babies, particularly if: 1. Weight <1500g 2. <34 weeks gestation 3. IUGR Consider iron supplementation in mixed fed infants if they are fed more breast milk than formula. Commence at 28 days of age. Continue up to 6-12 months of age depending on diet. Dose: 1ml per day or 0.5ml per day if mixed fed. Note: ESPGHAN recommends a dose of 2-3mg/kg/day. Iron supplementation may be started at 2-6 weeks of postnatal age. Anaemia of prematurity is not iron deficiency.
08.02.02	Tacrolimus Adoport^®	Prescribe by brand
08.02.02	Tacrolimus Prograf^®	Capsules 500micrograms, 1mg Prescribe by brand due to interpatient variability
08.02.02	Tacrolimus Advagraf^®	Capsules 500micrograms, 1mg Prescribe by brand For use by Renal Unit only
13.05.03	Tacrolimus Protopic^®
20	TALC BP purified sterile 4g,10g
08.03.04.01	Tamoxifen	Tablets 10mg, 20mg
07.04.01	Tamsulosin Hydrochloride	Capsules 400micrograms
13.05.02	Tars Cocois^®
13.05.02	Tars Coal Tar Paster BP
13.05.02	Tazarotene 0.05% Zorac^®
05.01.07	Teicoplanin Targocid^®	Injection 200mg & 400mg powder
04.01.01	Temazepam	Tablets 10mg, 20mg Liquid 10mg/5ml
05.01.01.02	Temocillin Negaban^®	Microbiology advice only
02.10.02	Tenecteplase Metalyse^®	Injection 8000units, 10000units Use in accordance with thrombolysis protocol.
24.01	Tentrini	Paediatric Nutritional Products List - approved APC 05/18
24.01	Tentrini Energy	Paediatric Nutritional Products List - approved APC 05/18
24.01	Tentrini Energy Multifibre	Paediatric Nutritional Products List - approved APC 05/18
24.01	Tentrini Multifibre	Paediatric Nutritional Products List - approved APC 05/18
24.01	Tentrini Multifibre	Paediatric Nutritional Products List - approved APC 05/18
24.01	Tentrini Multifibre	Approved by APC 05/18 for use by prescribers following: GUIDELINES FOR THE IN-PATIENT MANAGEMENT OF PAEDIATRIC PATIENTS WITH EATING DISORDERS (UNDER 16 YEARS) see link. Also on Paediatric Nutritional Products list - approved APC 05/18 see link
13.10.02	Terbinafine Hydrochloride 1% Lamisil^®
03.01.01.01	Terbutaline Sulphate Bricanyl^®	Turbohaler 500micrograms/dose Liquid 1.5mg/5ml
07.01.03	Terbutaline Sulphate	Injection 500micrograms/ml
06.06.01	Teriparatide Forsteo^®	Pre-filled pen 250 micrograms/ml For use by Consultant Rheumatologists and Dr Hammond only
06.05.02	Terlipressin Variquel^®	Injection 1mg
06.01.06	Test Strips Multistix 8SG^®
06.01.06	Test strips Contour
06.01.06	Test Strips Freestyle optium
06.01.06	Test strips Freestyle optium beta-ketone
06.01.06	Test strips Gluco Rx HCT
06.01.06	Test strips Gluco Rx Ketone
06.01.06	Test strips GlucoMen LX sensor
06.01.06	Test strips GlucoRx Nexus test strips
06.01.06	Test Strips: GluNeo test strips
24.01	Testosterone Restandol^® 40mg Testocaps	By specialist recommendation only. All monitoring is done by hospital specialist prescriber along with dose changes if appropriate during the 4 month treatment. The specialist will write to the GP with a standard clinic letter as appropriate. June 2018 APC.
06.04.02	Testosterone and Esters Sustanon 250^®	Injection 1ml (oily) - Testosterone propionate 30mg, testosterone phenylpropionate 60mg, testosterone isocaproate 60mg, testosterone decanoate Initiation on the advice of a specialist
06.04.02	Testosterone and Esters Testosterone (implant)	Implant 200mg Initiation on the advice of a specialist
06.04.02	Testosterone and Esters Testogel^®	Gel sachets 50mg Initiation on the advice of a specialist
14.05.02	Tetanus immunoglobulin
15.02	Tetracaine (Amethocaine) Ametop^®
24.16	Tetracaine (Ametop^®) Neonatal
11.07	Tetracaine Hydrochloride Minims^® Amethocaine Hydrochloride	Eye drops 1%
06.05.01	Tetracosactide Synacthen^®	Injection 250micrograms/ml
24.01	Tetracosactide (Synacthen)
09.02.02.02	Tetrastarch Volulyte^®	6% (500ml)
08.02.04	Thalidomide Pharmion^®	Capsules 50mg Patient authorisation form must be sent with each prescription
03.01.03	Theophylline	See under individual brand names Monitor theophylline plasma levels when prescribed concomitantly with calcium channel blockers, cometidine, ciprofloxacin, clarithromycin or erythromycin.
03.01.03	Theophylline Nuelin^® SA	MR tablets 175mg, 250mg Prescribe by brand. Monitor theophylline plasma levels when prescribed concomitantly with calcium channel blockers, cometidine, ciprofloxacin, clarithromycin or erythromycin.
03.01.03	Theophylline Slo-Phyllin^®	MR capsules 60mg, 125mg Prescribe by brand. Monitor theophylline plasma levels when prescribed concomitantly with calcium channel blockers, cometidine, ciprofloxacin, clarithromycin or erythromycin.
03.01.03	Theophylline Uniphyllin^® Continus	MR tablets 200mg, 300mg, 400mg Prescribe by brand. Monitor theophylline plasma levels when prescribed concomitantly with calcium channel blockers, cometidine, ciprofloxacin, clarithromycin or erythromycin.
09.06.02	Thiamine	Tablets 50mg, 100mg
09.06.02	Thiamine Pabrinex^®	IM injection IV injection
24.16	Thick and Easy Neonatal
15.01.01	Thiopental Sodium
04.08.01	Tiagabine Gabitril^®	Not stocked at HDFT Initiation on the advice of a Neurologist
12.02.01	Tiamcinolone Acetonide Nasacort^®	Aqueous nasal spray 55micrograms/metered spray
02.09	Ticagrelor Brilique^®	60mg tablets 90mg tablets
05.01.03	Tigecycline Tygacil^®	Injection 50mg powder For use on microbiology advice ONLY
24.01	Timolol 0.5% long acting eye drops (topical treatment of haemangioma)	Unlicensed indication of a licensed drug
11.06	Timolol Maleate	Eye drops 0.25%, 0.5%
11.06	Timolol Maleate Once-daily Timoptol^®-LA	Infantile haemangioma
24.01	Tinzaparin
02.08.01	Tinzaparin Sodium
03.01.02	Tiotropium Spiriva^®	Respimat® 2.5mcg/dose Handihaler® 18mcg/dose
03.01.04	Tiotropium / olodaterol Respimat Spiolto Respimat	Licnensed for COPD only
02.09	Tirofiban Aggrastat^®
10.02.02	Tizanidine	Tablets 2mg Initiation on the advice of a specialist
05.01.04	Tobramycin (Bramitob)	75mg/ml Nebuliser solution
05.01.04	Tobramycin Podhaler Tobi^®
10.01.03	Tocilizumab RoActemra^®
10.01.03	Tocilizumab RoActemra^®	Approved by the HaRD Area Prescribing Committee, January 2015
10.01.03	Tofacitinib Xeljanz	For initiation by Consultant Rheumatologists
07.04.02	Tolterodine Tartrate Detrusitol^®	Tablets 1mg (twice daily dosing)
07.04.02	Tolterodine Tartrate modified release Detrusitol^® XL	MR Capsules 4mg (once daily dose)
06.05.02	Tolvaptan Samsca^®	Patients requiring tolvaptan are managed by York Teaching Hospitals
04.08.01	Topiramate Topamax^®
24.01	Topiramate (migraine)
04.07.02	Tramadol Hydrochloride	Capsules 50mg Injection 100mg/2ml MR tablets - restricted to patients non-compliant with regular tramadol
02.11	Tranexamic Acid	Tablets 500mg; Injection 500mg/5ml
24.01	Tranexamic acid
08.01.05	Trastuzumab Herceptin^®
08.01.05	Trastuzumab emtansine Kadcyla^®	Approved in February 2014 as per Cancer Drugs Fund (CDF)guidelines
11.06	Travoprost Travatan^®	For when patients have poor response to latanoprost
11.06	Travoprost with Timolol DuoTrav^®
04.03.01	Trazodone Hydrochloride	Capsules 50mg, 100mg Liquid 50mg/5ml
08.01.05	Tretinoin	One box stored in Pharmacy EMCU. Out of Hours; please contact the on-call pharmacist
10.01.02.02	Triamcinolone Acetonide Kenalog^®
20	TRICHLORACETIC ACID 90% SOLUTION	Approved by HaRD Area Prescribing Committee January 2014 for Consultant Dermatologists use only.
04.02.01	Trifluoperazine	Tablets 1mg, 5mg Liquid 5mg/5ml
08.01.05	Trifluridine / Tipiracil Lonsurf^®	NICE TA405: Trifluridine–tipiracil for previously treated metastatic colorectal cancer
04.09.02	Trihexyphenidyl Hydrochloride	Tablets 2mg, 5mg Liquid 5mg/5ml (previously known as benzhexol)
02.06	Trimetazidine Unlicensed	MR Tablets 35mg For use by specialists as last line therapy for unstable angina
05.01.13	Trimethoprim	Tablets 100mg, 200mg Liquid 50mg/5ml
24.01	Trimethoprim
24.16	Trimethoprim Neonatal
08.03.04.02	Triptorelin Gonapeptyl Depot^®	Injection 3.75mg Paediatric use only for precocious puberty
11.05	Tropicamide Mydriacyl^®	Eye drops 0.5%
11.05	Tropicamide single use Minims^® Tropicamide	Eye drops 0.5%, 1%
07.04.02	Trospium Chloride Regurin^® XL
20	TUBERCULIN PPD 2TU Injection 20 units in 1 mL
24.01	Tuberculosis medicines
06.04.01.02	Ulipristal acetate Esmya^®	February 2018 Area Prescribing Committee - No new treatment courses to be prescribed following MHRA advice. Originally approved by the Area Prescribing Committee September 2012.
07.03.05	Ulipristal Acetate EllaOne^®	Tablet Ulipristal acetate 30mg To be used 72-120hourse after unprotected sexual intercourse
03.01.02	Umeclidinium Incruse® Ellipta	Licensed for COPD only.
03.01.04	Umeclidinium / vilanterol Anoro Ellipta®	Licensed for COPD only
02.08.01	Unfractionated Heparin	Sub-cutaneous injection 5000 units/0.2ml - for VTE prophylaxis if CrCl <10ml/min. Injection 1000units/ml (20ml ampoules) - for use as an infusion (see individual charts). Injection 50 units/5ml - For central lines and paediatric peripheral lines only. Heparinised saline 1000 units/500ml For use in cardiac unit only.
01.07.02	Uniroid HC	For Primary Care prescribing only; product not stocked at HDH
13.02.01	Urea 40% Special Preparation	50g Not kept as stock in pharmacy
07.04.04	Urinary Catheter Balloon containing Triclosan Farcofill®	For patients who require catheter changes more than once every 4 weeks or who require maintenance solutions more than once every 2 weeks. This was approved by the APC for 4 patients per District Nursing Team (North, South, East and West).
02.10.02	Urokinase Syner-KINASE^®	Injection 25000 units For thrombosed intravascular catheters and cannulae & peripheral vascular occlusion
24.01	Urokinase
01.09.01	Ursodeoxycholic acid Ursofalk^®	Capsules 250mg; Suspension 250mg/5ml
01.09.01	Ursodeoxycholic acid Ursogal^®	Tablets 150mg
13.05.03	Ustekinumab Stelara^®
24.16	Vaccines - primary immunisation course Neonatal
05.03.02.02	Valganciclovir Valcyte^®
04.02.03	Valproic Acid Depakote^®	Tablets 250mg
02.05.05	Valsartan Diovan^®	Tablets 40mg; Capsules 80mg, 160mg For heart failure post myocardial infarction only
24.01	Vamcomycin
05.01.07	Vancomycin	Injection 500mg & 1g powder (hospital only) Capsules 125mg
24.16	Vancomycin Neonatal
04.10	Varenicline Champix^®	Tablets 500micrograms, 1mg
14.05.02	Varicella-Zoster immunoglobulin
06.05.02	Vasopressin Pitressin^®	Injection 20units/ml
01.05.03	Vedolizumab Entyvio^®	Approved in line with NICE TA342 and NICE TA352
08.01	Venetoclax Venclyxto^®
04.03.04	Venlafaxine Efexor^®	Tablets 37.5mg, 75mg (Twice daily dosing) Doses above 300mg on the advice of a specialist (AMBER-shared care)
04.03.04	Venlafaxine Efexor^® XL	Capsules 75mg, 150mg To be initiated only in patients non-compliant with twice daily dosing. Doses above 300mg on the advice of a specialist
02.06.02	Verapamil Hydrochloride	Tablets 40mg, 80mg, 120mg; Injection 5mg/2ml (hospital only)
11.08.02	Verteporfin Visudyne^®	Injection 15mg
04.08.01	Vigabatrin Sabril^®	Tablets 500mg Sachets 500mg Initiation on the advice of a Neurologist
08.01.04	Vinblastine Sulphate
08.01.04	Vincristine Sulphate
08.01.04	Vinorelbine
09.06.07	Vitamin and mineral suppliments Forceval^®	Capsules and soluble tablets Approved July 2018 APC meeting for Refeeding protocol - see link
09.06.02	Vitamin B complex preparations Vigranon B^®	Long-term manufacturing problem
09.06.02	Vitamin B Tablets (Compound Strong)	Contain nicotinamide 20mg, pyridoxine 2mg, riboflavin 2mg, thiamine 5mg
20	Vitamin D - Colecalciferol 25micrograms (1000units)	Licensed as a dietary supplement
24.16	Vitamin K (phytomenadione) Neonatal
10.03.02	Voltarol Emulgel^®
05.02.01	Voriconazole	On the advice of a specialist
24.01	Warfarin
02.08.02	Warfarin Sodium
09.02.02.01	Water for Injection	5ml, 10ml, 20ml, 100ml
13.02.01	White Soft Paraffin BP	500g
02.02.01	Xipamide Diurexan^®
12.02.02	Xylometazoline Hydrochloride Otrivine^®	Nasal drops 0.1% Paediatric nasal drops 0.05%
13.02.01	Yellow Soft Parrafin BP	15g
13.02.01	Zerodouble gel
13.02.01	Zeroguent cream
13.02.01	Zeroveen^®	Not stocked at HDH
24.16	Zidovudine Neonatal	Follow BHIVA guidelines
20	ZINC & SALICYLIC ACID PASTE BP (lassars paste) 60g
13.02.02	Zinc and Caster Oil Ointment BP	15g
09.05.04	Zinc Sulphate	Effervescent tablets 125mg(45mg elemental zinc)
06.06.02	Zolendronic Acid Aclasta^®	Injection 4mg Injection 5mg Initiation on the advice of a specialist
04.08.01	Zonisamide Zonegran^®	Capsules 25mg, 50mg, 100mg Initiation on the advice of a Neurologist
04.01.01	Zopiclone	Tablets 3.75mg, 7.5mg First choice hypnotic in primary care
04.02.01	Zuclopenthixol Acetate Clopixol Acuphase^®	Injection 50mg/ml
04.02.02	Zuclopenthixol Decanoate Clopixol^®	Injection 200mg/ml, 500mg/ml
04.02.01	Zuclopenthixol Dihydrochloride Clopixol^®	Tablets 2mg, 10mg, 25mg

Harrogate & Rural District Formulary